incivo works by stopping the virus from multiplying and infecting people with hepatitis c infection . incivo is used to treat chronic hepatitis c in adult patients ( aged 18 years and older ) who have already been treated with peginterferon alfa , ribavirin and telaprevir . incov belongs to a class of medicines called ns3 - 4a protease inhibitors . the ns3 + 4a enzyme is essential for the hepatitis c virus to multiply and infect other people . inciv is used in combination with peinterferone alfa and ribavir . your doctor has prescribed incivo for you
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been prescribed peginterferon alfa and ribavirin in addition to incivo . warnings and precautions talk to your doctor or pharmacist before taking incivo : if you currently take peginerferon avfa and / or ribavir . incivo should not be taken with the following medicines : if severe side effects have been reported 56 if you take the medicine alfuzosin ( for symptoms of an enlarged prostate ) alpha - 1 - adren
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose regimen is as follows : the recommended dosage regimen is 3 mg twice a day ( taken 6 hours apart ) taken 2 to 8 hours apart . the dose may be adjusted by your doctor if necessary . children and adolescents the recommended doses for children and adolescent aged 6 years and older are the same as for adults . this is because both hepatitis c virus infection and human immunodeficiency virus infection ( hiv ) are not fully controlled with efavirenz . the doctor will advise you on
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may develop other symptoms . the severity of a severe skin reaction may be life - threatening . tell your doctor immediately if you develop a skin rash . your doctor may decide to treat your rash with other treatments . other symptoms that may be associated with a rash include : fever , tiredness , swelling of the face , swellingof lymph glands , a wide - spread rash , peeling skin , fever , flu - like symptoms , painful skin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do this after the first opening of the bottle . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo delivers 375 mg telaprentir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbinbryt contains the active substance daclizumab beta , a monoclonal antibody . what zinryta looks like and contents of the pack zininbrysta is a type of protein that is present in the body . it is used to treat multiple sclerosis in adults . it can be used as therapy or as two ms treatment with other treatments . inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms ( repeated
do not take zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from liver problems , tell your doctor before taking zinibryta . if you are suffering from any other autoimmune disorders , tell the doctor before you start taking zirinbrya . if any of these apply to you , tell them before you take zirinibrya : if you take any other medicines , including herbal supplements . if your doctor has told you to take any medicines , especially supplements that may increase liver
your doctor or nurse will give you zinbryta exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much zinbaq is given the usual dose of zinburyta is 150 mg . your doctor will ask you to have a blood test to check how well your liver is working . the usual starting dose of the medicine is one vial of zinfryta 40 mg . this blood test is repeated every three weeks . your dose may be increased or decreased depending on your response to a blood sample . how zinboryta will be given
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems ( very common : may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : may effect up to 1 in 100 people severe inflammation of the liver may lead to death . tell your liver doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . before you start using a new syringe / pen , use a refrigerator to remove the pre - drawn syringe from the refrigerator . zin bryta syringes / pens may be stored for
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . 1ml of solution contains sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ) ( see section 2 ' zin bryta contain sodium '). what zinbaryta looks like and contents of the pack zinbubta is a clear to slightly yellow solution for injecting into a syringe / pen ( pre -
what wilzin is wilzin belongs to a group of medicines called metabolism products . what wilson ' s disease is wilson ', a rare inherited defect in copper excretion , is thought to have been present in the liver , eyes and brain . this may cause liver damage , neurological disorders , and in particular in the intestine and its further accumulation in the body . what is wilston ' s medicine used for wilzin ? this treatment is used to treat wilson '.
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . your doctor will monitor your condition during and after the treatment and may adjust the dose of blood and urine if necessary . sufficient treatment and monitoring should be performed 25 if insufficient treatment ( copper excess ) is required .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : 25 mg and 50 mg : 1 capsule of wilzin 50 mg in 2 capsules of wilz 25 mg in 1 capsule each dose of wilzan 50 mg is 2 capsules each dose each dose . wilzin 25 mg : 50 mg once a day in 2 capsule each treatment cycle of wilzar 25 mg is 1 to 6 capsules each treatment cycles of wilin 25 mg once daily in 6 capsules every 16 capsules each 57 capsules each 1 capsule in wilzin is 25
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ): very common : may affect more than1 in 10 people not known : frequency cannot been estimated from available data . if you experience any of these effects , contact
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule also contains 25mg of zinc , equivalent to 167 . 84 mg of the zncp ( zn cp ) ( as zinc acetates dihydrates ). the other ingredients are magnesium stearate and water for injections . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off
biktarvy contains the active substances bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretroviral medicine named a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) in adults . bikttarvy reduces the risk of infection with hiv by
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these , tell your doctor . if you have recently taken any of any of your following medicines : - rifampicin used to treat some bacterial infections , such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to help you sleep and / or relieve depression and anxiety . warnings and precautions talk to your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your diet should be taken in combination with aluminium and magnesium hydroxide mineral supplements and vitamins such as magnesium and iron . see section 2 " important information about these medicines ". if you take more biktarvy than you should if you accidentally take too many tablets , contact
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : inflammation or infection in patients with advanced hiv infection ( aids ) or opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur soon after hiv treatment is started . these symptoms may be due to an improvement in the body ' s immune response , enabling the body to fight infections that have no obvious symptoms . autoimmune disorders ( when the immune system attacks healthy body tissue ) are common in patients taking medicines for hiv illness . autoimmune conditions occur many
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each bikttarvy tablet contains bic tegravira sodium equivalent to 50 mg bicchegravor , 200 mg emtrititabrine and ten ofovir aluminiumafenate fumarate equivalent to 25 mg tenofavir alufenamide ). the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium
novondorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your blood glucose may be increased when you start taking novonor on its own or in combination with metformin . if you have diabetes , novon
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor . if you have type 1 diabetes . the acid level in your blood may increase ( diabetic ketoacidosis ). if you suffer from a severe liver disease . if your doctor has told you that you are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 if you know that you have liver problems . novonors should not be used if you think you have moderate liver disease , as novonere may not be suitable for you . if any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the usual starting dose is 30 mg once daily for 4 weeks . your doctor may increase your dose to 30 mg every 16 weeks . if you take more novonor than you should if you accidentally take too many tablets , contact your doctor straight away . your blood sugar may go up ( see section 2 ). if you have a hypo ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , you should contact your doctor immediately . hypoemic reactions are generally mild / moderate . however , hypoglycemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction ). other side effects
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ) only in 1 mg tablet and iron oxide red ( e 172 ) only only in 2 mg tablet . what novonor looks like and contents of the pack novonorg tablets are white , round , flat , with " 0 . 5 " marked
pumarix is a vaccine used to protect adults ( aged 18 years and older ) against pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemicflu is similar to ordinary flu but may be more serious . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients of the vaccine ( e . g . chicken protein , ovalbumin , formaldehyde and sodium deoxycholate ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if this happens , the vaccine may not fully protect you and you may require medical treatment . if you experience an allergic response to any ingredients of pumarip , stop using this vaccine and 33 talk to your doctor .
pumarix is intended for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 vaccine . pumix is used to prevent children from being born prematurely . pumanix is recommended for use by adults aged 3 - 9 years and in children aged 10 - 17 years . how pumarik is given pumarax is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may be life - threatening . if you get dangerously low blood pressure , shock may be severe and you may need emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where thejection is given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the suspension after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the vaccine , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 30 . do away with pumarix if you notice any particles in the solution . do throw away
what pumarix contains the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which are used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - Î± - tocopherol , polysorbate 80 and adjuvants are used in addition to the vaccine . the ingredients are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water for injections . what p
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . when used in combination with gallium (" 68ga ") edotreaotide , this procedure allows the doctor to obtain more information about the amount of gallium and edotreeotide in your body . somakit to is given into a vein or into body areas as a medical imaging procedure called positron emission tomography ( pet scan ). this medical procedure allows images to be taken of the abnormal cells and tumours . your disease will be closely
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had allergic reaction to any ingredient listed in the section 4 of this leaflet . warnings and precautions talk to your doctor or pharmacist before taking somaknittoc if : you have kidney or liver problems you have renal or hepatic disease you are under 18 years of age . you have dehydration . your doctor will discuss with you the possibility of having the examination during the 28 days after you have taken somakt . you suffer from others medical conditions that affect the
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc must not be used in children and adolescents below 29 years of age . the nuclear medicine doctor supervising the procedure will decide on the quantity of somakt to be used . the quantity to be administered depends on the age of the child and the type of radiocquerel being administered . the doctor will decide the quantity that is appropriate for the child . the usual dose of somackit to be given is one 100 mg or two 200 mg megabecquerels per kilogram body weight . administration of
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) which have been reported after administration of somakit to patients with symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . the site of the injection may be exposed to low amounts of ionising radiation ( which can be very sensitive to the presence of cancer and hereditary abnormalities ). reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be done by the specialist . somakit t will be stored at a concentration of 4 to 25 mbq / dl . do not use somakito if you notice any visible signs of deterioration . radioactive products should be disposed of in accordancewith local requirements .
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg of edotreaotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakt t looks like and contents of the pack somakiton t is presented as a radiopharmaceutical preparation in a glass vial with black flip - off cap . it is a white powder supplied
afinitor is an anticancer medicine containing the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor acts on the hormone receptor ( hormone receptor ) in patients with positive advanced breast cancer ( postmenopausal women ) who are treated with non - steroidal aromatase inhibitors ( so - called " serms "), which are used to keep the disease under control . afinavitor is used in combination with a medicine called exemestane ( a steroid aromase inhibitor ) and hormonal anticancer therapy in adult patients with advanced tumours ( neuroendocrine tumours
you must not be given afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before you are given afginitor : if you think you may be allergic to everolimus , sirolimus , temsirolimuses or any of the other ingredients of this medicine ( listed in section 6 ). if you suspect you may also be allergic , talk to a doctor or nurse before you receive afincer . if you have any problems with your liver . if any disease affects your liver , your doctor may prescribe a different dose of afinin . if your doctor has prescribed af
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg taken once a day . your doctor may prescribe a lower dose of afinitor ( 5 mg ) to be taken once daily . the dose may be increased to a maximum of 5 mg or lowered to a minimum of 7 . 5 mg once daily if certain side effects occur . your dose of the active substance in afininitor will depend on how you respond to treatment . if you take more afinit than you should if you have taken more tablets than
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience an allergic reaction including : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps . other side effects of afincer may include : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation of the lung ( pneumonitis 46 common ( might affect up to 1 in every 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do open the blister and take the tablets with you . do this once a day . donot use this product if you notice any visible sign of tampering . do so after the time you have taken the tablet . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect
what afinitor contains the active substance is everolimus . afinit 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablets : each film - coated tablet contains 5 mg of Everolimus in each film coating . afincitor 10 mg tablets: each film- coated tablet delivers 10 mg of of everlimus in one film - coating . the other ingredients are butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactase anhydrous . what afin
what laventair ellipta is the active substance of lavent air ellipta . it contains two active substances called umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laventAir ellipta looks like and contents of the pack laventairy ellipta comes as a clear , colourless inhalation . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur every day . in copd the muscles around the airways tighten . this medicine blocks
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . warnings and precaution talk to the doctor or nurse before using lavent air ellipta if you : have asthma , heart problems , high blood pressure , or have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). have epilepsy , thyroid gland problems , diabetes
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day . if you use more lavent air ellipta than you should if you have used more lavents than you have been told to use , contact your doctor immediately . symptoms of using too much laventour ellipta include a sudden attack of breathlessness and wheezing . if this attack does not go away , you may need
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , have difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties immediate breathing difficulty stop using Lav
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umebolidinia ( equivalent to 65 microgram ) umecylidinIUM bromides and 22 microgram s of vilancerol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ') and magnesium stearate . what laventAir ellipta looks like and contents of the pack laventAIR ellipta is an
tovya contains the active substance guselkumab , which is a monoclonal antibody . this medicine contains the type of protein called il - 23 . tremfya is used to treat psoriasis in adults with moderate to severe " plaque psorism ". plaque psoreiasis is an inflammatory condition that affects the skin and nails . tremfiya works to improve the condition on the skin , and to reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and risks talk to the doctor or nurse before using this medicine if you : have an infection or an infection with tuberculosis 36 have an illness or symptoms of an infection that you are not sure about talk to a doctor or hospital pharmacist if you get infections or allergic reactions during treatment with
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 micrograms solution for injection ( 1 pre - filled syringe ) is given under the skin ( subcutaneous injection ) every 4 to 8 weeks . you should not inject tremfia more than once a week . if you use more tremfyna than you should tremffa should be injected under the control of a doctor or nurse . if possible , tremfja may be given to you by a doctor , nurse or pharma . if necessary , tremfaya may be
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious ( may affect up to 1 in 10 people ): upper respiratory infections common side effects ( may effect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not give this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this if you have
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . tremfia is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 ( 2 packs of 1 )
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins ( a hormone that lowers blood pressure by relaxing blood vessels ). prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ), in adult patients whose condition is persistent or recurrentcteph . it is used in adult adult patients who are unable to complete surgical treatment and whose exercise capacity is reduced . symptoms of the disease are similar to those of chronic thromeboembolmonary
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - warnings and precautions talk to your doctor or pharmacist before taking trepulemix - tell your doctor if your baby has a heart problem . - tell the doctor if the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) in the abdomen or thigh . trepanmix is supplied in a pouch containing a portable pump containing your treprostinil . the pump is connected to the infusion line to reduce the risk of accidental overdose . the recommended dose is 1 mg / kg body weight ( kg ) once daily , followed by 2 . 5 mg /kg body weight once daily .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in 100 people ): dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ), swelling of feet , ankles , legs , fluid retention , hot flush pain in arms and / or legs 36 uncommon ( may effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do away with the vials after the first use . do this if you notice any visible sign of damage such as discolouration or other signs of deterioration . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ). each 10 ml vial of 10 ml contains 10 mg trepristinila ( as water for injections ). each 2 . 5 ml vials of 2 . 75 ml contains 20 mg trestinill ( asodium salt ). one 10 ml ampoule of 25 ml contains 30 mg trepropstinIL ( as solution for injections ) and one 50 ml ampule of treproprostinusil ( sodium salt ) and
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enocriptine . it works by : 1 ) stopping existing blood clots from forming . 2 ) stopping blood clubs from forming in your blood . thorination is used to : prevent blood clumps from forming within your blood during or after an operation . to treat an acute illness ( unstable angina ). to help protect your heart after a heart attack . to prevent bloodclots from getting into your dialysis machine . to help prevent severe
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have had a reaction to heparrin , such as a severe drop
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . it is used when the bleeding is not controlled or when there is any bleeding event . in some cases , excessive bleeding may be life - threatening . exceptional weakness , tiredness , paleness , dizziness , headache , unexplained swelling . tell your doctor immediately , or stop taking your medicine . if you have any of the following while taking thorinan : - a severe allergic reaction , including difficulty breathing , swelling of the lips , mouth , throat or eyes , blockage of a blood vessel or a blood clot , cramping pain
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe label after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . one ml contains 100 mg of enoxapearin sodium ( as enoxabarin sodium ). each pre - filled syringe contains 0 . 2 ml of solution for injection , equivalent to 2 , 000 mg of the active substances in the solution . the other ingredients are enoxafarin sodium and water for injections . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene
sensend contains the active substances lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which increases the rate of ejaculation .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senststend . if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anaesthesia ). if you suffer from a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ), anaemia ( methaemoglobinaemia ). if any of these apply to you , tell your doctor before using this medicine . warnings and symptoms
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is one spray of senstend 3 times a day ( 3 times per day ). the recommended starting dose is 1 spray of 1 ml on the head of your penis . after that , the recommended maximum dose is 3 sprays of 24 ml ( 4 times per night ). the spray container should be used immediately after the pump malfunction . avoid direct contact with eyes , nose , mouth and ears . the pump should be stopped at least 1 hour after removing
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to1 in 100 people ) headache local irritation of the throat , irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the part of your penis pain or discomfort in the pris itching in the region of your vagina a high temperature other side effects very common ( might
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer after this period . puncture the container before use to prevent it from burn . do this if you notice any particles in it . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilacaine . one spray container contains 50 ml of lidocane and 7 . 5 ml of prilaine . - each spray container provides 2 . 5 mg of prlocaine per ml . what senstends looks like and contents of the pack each spraycontainer contains 6 . 5 to 20 ml of clear , colourless to light yellow cutaneous spray . each spray can be individually packed in a carton containing 5 or 12 sprays . each pack
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . in adults melanoma is advanced and needs complete resection in adults ( treatment including surgery and adjuvant therapy ). advanced non - small cell lung cancer ( a form of lung cancer ) adults advanced renal cell carcinoma ( advanced kidney cancer ) and adults classical hodgkin lymphoma ( when previous therapies have failed or cannot be used ), including an autologous stem - cell transplant ( a transplant that reduces the amount of stem cells produced ). advanced cancer of the head and neck ( a kind of adults advanced uro
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using opdivor if you : - have problems with your heart ( a change in the rhythm or the heartbeat ) - have an abnormal heart rhythm - have any problems with any of your lungs ( breathing difficulties or cough ) - inflammation of the lungs ( pneumonitis or interstitial lung disease ) - diarrhoea ( watery , loose or soft stools ) - any symptoms of inflammation of any intestines ( colitis ) -
how much opdivo is given the recommended dose of opdivos is 240 mg given as 2 mg once a week ( corresponding to 480 mg per 4 weeks ). the recommended amount of opiono given in combination with ipilimumab is one tablet per day . the treatment will be started by a doctor who is experienced in the treatment of skin cancer . the recommended dosage of opDivo is 1 mg of nivolumab per kilogram of your body weight . the dose will be adjusted every 4 weeks . the usual dose of ipilimab is two tablets per day ( correspondingto 240 mg per 2 weeks
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and refrigerate ( 2 8 ). do not freeze . after dilution , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg or 240 mg of 24 mg of the active substances . the other ingredients are : nivodumab , sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections . what opdiv
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel tad 30 if you are allergic to clopipidogel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrel tart . warnings and precautions the following apply to all people taking clapidogl tud : if you think you may be at an increased risk of bleeding if you : have amedical condition that
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl to be given orally once at the start of each 75 - day period of treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopidaogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopidiogrel tetad looks like and contents of
tacrolimus contains the active substance tacrolimu . tacforius is an immunosuppressant . after your organ transplant ( liver and kidney ), your body ' s immune system will try to reject the new organ . tacfortius is used to prevent rejection of transplanted organs by patients who have already received their liver and kidneys , and who have failed to respond adequately to any previous treatment after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before taking tacforus if you : - are allergic , to sirolimus , to any macrolide ( antibiotic ), to erythromycin , clarithromycin or josamycin . tacrolinus immediate release capsules ( e . g . , tacni ) are not suitable for patients who are unable to swallow tac
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . your doctor will prescribe the same tacrolimus medicine for you . if you have had a transplant , your doctor may prescribe a different tacrolemus medicine . always take this medication exactly as described in this leaflet . check the box at the end of this leafle leaflet for information about taking this medicine . if the dose is too low , your physician may prescribe the right medicine to treat the rejection of your
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must stop taking tacforius and seek medical attention immediately if you notice any of the following serious or severe effects : allergic and anaphylactic reactions ( benign and malignant tumours ) have been reported during tacforia treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ) and agranulocytosis ( a severely lowered number of white blood cells ) have also been reported . haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . discard 1 capsule after opening the aluminium wrapping . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg prolonged - release hard capsules hard gelatin capsules : each capsule contains 1 mg of tacrolamus ( as monohydrate ). tacforia 3 mg prolonged release hard gelatin capsule : each capsules contains 3 mg of t tacrolemus (as monohydrate ) . tacofius 5 mg long - release capsules :each capsule contains 5 mg of of tacrulimus ( monohydrate ), each capsule has capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . capsule shell
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelzentiva . warnings and precautions the following apply to all of you : if any part of you is taking clapidogel zentva : if your risk of
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the blister in the original carton in order to protect from light . clopidogrel zentiva may be used in aluminium blisters if it is stored below 30 . do this if you notice that the tablets are damaged or there are particles in them . do away with clopridogrel zincentiva if you see
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopigrel ( as hydrogen sulphate ). ( see section 2 ' clopiderel zenta contains lactose ' and ' clogidogl zentva contains hydrogenated castor oil '). the other ingredients are mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), tri
yttriga is a radioactive medicine that is stored in a refrigerator ( 2 - 8 ). it is used in combination with another medicine that has been prepared in tiny radiation doses . the treatment is a radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you are pregnant or think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yttrida - yttrada is a radioactive medicine . it is used in combination with another medicinal product called radiopharmaceuticals . yttrine contains radioactive material . radioactive medicinal products are stored at 2 to 16 in the outer carton . other medicines and yttarga tell your nuclear doctor if you or your nuclear carer are taking , have recently
the treatment should be supervised by a doctor experienced in the diagnosis and treatment of specific diseases . the treatment should continue under the supervision of a physician experienced in diagnosis and appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage will be in accordance with local regulations on radioactive substances . any unused product or waste material should be disposed of in accordancewith local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttrada looks like and contents of the pack yttrida is a clear , colourless type i glass vial with a 10 ml clear , clear , liquid solution with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in patients who have not received prior chemotherapy . cimbra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will decide how much ciamba you should receive . patients with lung cancer if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy , ciamra is a treatment for
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamba ( listed in section 6 ). - if breast - feeding is not recommended during treatment with ciamBra . - if your child has recently received a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using ciamra if you have or have had problems with your kidneys . before each infusion of cimbra , your doctor will check your blood , kidney and liver function to make sure that you have enough blood cells and that you are receiving ciamb
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out your dose based on this body surface area and will adjust your dose depending on your response to treatment and on your blood cell counts . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into one of your veins . the infusion will last approximately 10 minutes
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash ( common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do away with the reconstituted solution . do this if you notice any particles in the infusion solution . if the infusion mixture is not clear and colourless , it should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the
what ciambra contains the active substance is pemetrexed . each vial of ciamba 100 mg contains 100 mg of pemetreed ( as pemetresed disodium hemipentahydrate ). each vials of cimbra 500 mg contains 500 mg of the active ingredient pemetereed (as pemetretrexed dis sodium hemipontahydrates ). after reconstitution , the solution contains 25 mg / ml of pemrexed without further dilution . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ), sodium hyd
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam can help to control certain infections in your blood . immunogaman can be used in adults with increased levels of human hepatitis b immunoglubulins and immunoglofulin g ( ig ) in blood plasma of screened patients . immunoglogam is used to treat hepatitis b virus in haemodialysed patients . vaccination is initiated when a hepatitis b carrier ( antigen ) is known to produce an immune response that is stronger than those without measurable hepatitis b antibodies . vaccination may be continued as long as continuous prevention
immunogam should not be given : if you have an allergic reaction to human immunoglobulins or other blood products if you suffer from an iga deficiency if you had an allergic response to iga containing products in the past . children and adolescents immunogam is not recommended for use in children and teenagers under 18 years of age . immunoglubulins have not been studied in this age group . signs of adverse reactions include chills , headache , fever and vomiting . allergic reactions including nausea ( arthralgia ), joint pain and low blood pressure have been reported . moderate low back pain has been reported
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be administered in accordance with human hepatitis b immunoglobulin ( administration prevention ). the recommended dose for hepatitis b in healthy adults is 500 mg given every 24 hours for 72 hours . the recommended recommended dose of hepatitis bin haemodialysed patients is 500 Î¼g given every 2 weeks . seroconversion is recommended in order to ensure that vaccination with hepatitis b is fully effective in combination with a hepatitis b virus carrier . the hepatitis b antigen should be
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogams : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) rare ( affects less than 1 users in 1 , 000 ) very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) very common : affects less to 1 user of 10 , 000 not known : affects 1 user per 10 ,000 not known frequency cannot been estimated from available data undesirable effects have occurred during clinical trials
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do do not give immunogaman if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogaman 1 mg / ml solution for injection contains 5 mg of human plasma protein ( antigen ) 96 % ( expressed in ml ) the other ingredients are polysorbate 80 . what immunogams looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . it comes in a pack of 1 vial with or without needle .
remicade contains the active substance infliximab . infliximaab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfÎ± ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis remicades is used in adults , adolescents and children aged 6 years and older . these include cro
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these ingredients if you have tuberculosis ( tb ) if your doctor thinks you may have another serious infection such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you take reminade more often than you should if you accidentally take more remicad than you were told to in the past , tell your doctor or pharmacist immediately . if possible , rem
the recommended dose is : rheumatoid arthritis : 3 mg for every kg of body weight . psoriatic arthritis : ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases : 5 mg for each kg of person body weight , taken once a day . how remicade is given remicine will be given to you by your doctor or nurse . it is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be administered once a week .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . if you experience any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction : - swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild to severe and usually disappear within a few days . an allergic response is usually mild and usually
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . do away with remicade if it is not used immediately . infusion - related storage times and conditions are the responsibility of the user and would normally not be longer than 3 hours at 2 8 and 28 , but may be longer if kept at room temperature for an additional 24 hours . do this if you notice that
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixab . after reconstitution , each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicada is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicad is available in packs containing 1 , 2 , 3 , 4 or 5 v
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson ', s disease ). with parkinson's disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body that is important for movement control . rasagilinea mylan increases the amount of dopamine that is produced in the brains .
do not take rasagiline mylan - if you are allergic to rasagailine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression in parkinson ' s disease . it is also a strong pain killer . it has been shown to affect the ability of some people to take it . your doctor may advise you to stop rasai
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at the same time each day . you should take rrasagilrine mylan every day until your doctor tells you otherwise . if you take more rasgiline than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the rasaga mylan carton . if more rrasaga myl than you have been told to take , contact a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with rasagiline mylan as a combination of placebo and vial : the frequency of the side effects listed below is defined using the following convention : very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare uncommon abnormal movements in adults (â¥ 1 year old ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasageiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize ), talc , stearic acid . what rasaggiline melan looks like and contents of the pack rasagleiline tablets are 11 . 5 mm x 6 mm , biconvex tablets debossed with " r " on one side and " 1 " on the
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , including tuberculosis . symptoms of infections may include fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . - tell your doctor if the patient has a serious heart condition . - allergic reaction . allergic reactions may include symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . if the person has any of these reactions , tell your child ' s doctor . -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years old weighing 10 kg or more : one 30 mg tablet of hulio 20 mg / ml twice a day in children 2 to 16 years old weigh 30 kg or less hulios 40 mg /ml twice a daily in children 3 to 17 months old weighing 30 kg and less hula 40 mg twice a morning in children 6 to 17 year old weighing less than 30 kg hulia 40 mg per day in
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects ( which may occur up to 4 months after the last hulio injection ): allergic reaction including heart failure severe rash or hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection include fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired , coughing
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hulIO 40 mg is a sterile solution for injection containing 40 mg of adalimab in 0 . 8 ml of solution . the solution is clear to slightly opalescent and has a rubber stopper . hullio is available in packs containing 1 , 2 , 1 sterile injection syringe , 1 syringe needle
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have asthma or skin allergy ( intense inflammation in your nose ). warnings and precautions talk to your doctor or pharmacist before using yellox if you : - are using other nsaids ( e . g . acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used with topical steroids ( e. g . cortisone ) to reduce unwanted side effects
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye ( s ) twice a day . the recommended daily dose is 2 drops in the morning and 2 drops on the next day following your cataract surgery . method of administration yellox is for oral use . wash your hands with soap and water . remove the eye drops from the bottle cap and remove the bottle . twist off the bottle , pointing down , between your thumb and fingers , and tilt your head back . pull down your eyel
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
duzveo contains sufentanil , which belongs to a group of strong painkillers called opioids . suffentenil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuuveo may affect your breathing during treatment . you have recently had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate or irregular heartbeat . you are suffering
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is only suitable for adults . you should swallow the tablet whole with a glass of water . you can take this medication with or without food . dzuveo must be taken with strong painkillers such as sufentanil at least 30 minutes before or after food . the sublingual tablet must be swallowed whole with the disposable single -dose applicator provided in the pack . the applicator is inserted into the tongue . the tablets dissolve in the liquid and should not
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , especially slow and shallow breathing . if you get any of these side effects you must stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) are inability or difficulty sleeping , feeling anxious or confused , dizziness , headache
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do this medicine if you notice any visible signs of deterioration . do tell your pharmacist if you are concerned that the solution may have been accidentally frozen . medicines should not be disposed of via wastewater or household waste . ask your pharmacy how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine , stearic acid and magnesium stearate . what dzuvello looks like and contents of the pack dzuvelo is a white to off - white , round oval tablet with " 30 " debossed on one side and " 3 " debottled on the other side . it is supplied in
what erleada is erleADA is a cancer medicine containing apalutamide that is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be treated with surgical treatments . it is also used to prevent adult men from having sensitive prostate cancer which has spread beyond the original prostate tissue and cannot receive surgical treatment . it works by reducing the levels of testosterone in the blood . what erlead is used for erleade is used in adult men who have resistant prostate cancer . erleda also works by blocking the action of androgens , which are involved in the growth and spread of
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be pregnant . - if if you think you may ( or might become pregnant ) if you have a problem with your pregnancy ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine should not be given to children or adolescents . this is because the effects of this medication on the unborn child may be limited . - tell your doctor if you or your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . taking this medicine by mouth is the best way to get the best results . you should swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . erleade can be taken with or without food . other medicines and erlead tell your doctor if you take , have recently taken or might take any other medicines
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( dress ) has been reported with serious side effects . if you have any of these side effects : fit ( seizure ) has occurred uncommonly
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalectamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - film - coating : iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e 171 ). what erlead looks like and contents
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for the scan ( a pet scan ) in adult men who have previously had treatment for prostate cancer . it may be used in combination with other tests to determine prostate specific antigen ( psa ) and the cancer . an axumin pet scan is performed to find out if the cancer has spread to other parts of the body . the scan will be recorded on the patient alert card . your doctor or nurse will record the name of the patient and batch number of the product .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . - axumin is given once a day for a day . the axumin scan will last for 4 weeks . - before the scan , you will be given your usual medicines to take the latest 60 minutes before the axus injection . - urination will be checked during the scan . children and
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use this medicine safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used in each case . the usual dose is 370 megabecquerel per kilogram of body weight . how axumin is given and during the procedure axumin must be injected into a vein by a flush of sodium chloride
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) the effects of the medicine were mild . common ( effects in 1 to 100 users in 1 , 000 ) the side effects of axumin in 1 - 100 users were pain , rash , altered taste in the mouth , altered sense of smell . the safety and efficacy of this radiopharmaceutical have not been established . ionising radiation is a very sensitive type of radiation and is especially sensitive to the presence of certain types of cancer and hereditary
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . axumin will be stored under special conditions .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( as as asasasas ). each vials of 1600 mg contain 16000 mg of axumin . each vinal of 3200 mg contains 3200mg of fluiclovin ( asas asasrasasas ) and 3200 micrograms of 32000 microgram ( ascasasas). - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . these help to reduce pressure within the eye . azopt eye drops help to relieve high pressure in the eye , which can lead to an illness called glaucoma . the pressure in your eye increases , and this can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt . the same allergy may apply to some patients : if you develop too much acidity in your blood ( hyperchloraemic acidosis ). if this happens , stop taking azop and tell your doctor straight away . if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes . azop is used for the eyes only . 1 drop in each eye should be used in the eyes . 2 drops in each eyes should be taken once a day . 3 wash your hands before using the azopt bottle . twist off the cap . remove the cap and snap collar . hold the bottle , pointing down , between your thumb and a finger . tilt your head back . pull down your eyelid with a clean finger and insert a ' pocket ' between the eyel
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects ( might affect upto 1 in 100 people ) ( effects in : the eye ): sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzaolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( to maintain acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack
what forxiga is forxigo contains dapagliflozin . it belongs to a group of medicines ( medicines taken by mouth ) used to control diabetes in adults . it is used to lower the amount of sugar in your blood when you are older than 18 years . what forxig is used for forxinge is used in adults to treat two types of diabetes : type 1 diabetes : where your body does not make enough insulin or the insulin that your body makes does not work as well as it should . in both types of diabetic , your body may either make too much insulin or not enough sugar . this can
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor before taking this medicine : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is 10 mg once a day ( 5 mg twice a day ). if you have a liver problem , your doctor may lower your dose of the medicine to half a mg once daily . your doctor will also tell you how many tablets of for xiga to take . for type 1 diabetes : the recommended starting dose is 5 mg once weekly ( 5 tablets ). taking this medicine swallow the tablets whole with a glass of water . you can take forxigo with
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( very rare , may affect up to 1 in 10 , 000 people ). angioingema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( very common , may affects more than 1 in 1 , 000 persons ) if you have type 2 diabetes , the rare , but very rare ( may affect more than1 in 10 people ) if your condition is not controlled with diet and exercise , you may experience diabetic ketoat
what forxiga contains - the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . - the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone ( e1201 ), silicon dioxide ( e171 ), magnesium stearate ( e470b ). film - coating : polyvinyl alcohol ( partially
mifamurtide works by stopping the growth of certain bacteria which are resistant to the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults and children aged 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy is not able to stop cancer cells from growing . it also prevents cancer from coming back .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines containing ciclosporin or other cineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids can affect your heart or blood vessels , which may result in blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor treatment
treatment mepact will be given to you by a doctor or nurse . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much mepat to use the recommended dose is 2 mg mifamurtide once a day . your doctor will decide how many doses you need . the recommended doses are 12 mg and 24 mg . your dose may be adjusted by your doctor depending on your mepact treatments and on your chemotherapy schedule . your chemotherapy will be repeated every 36 hours . how to prepare treatment mepacts is prepared by a special process called
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients receiving mepACT ( transient ) paracetamol . if you experience fever during treatment with mepaction , you should contact your doctor immediately . stomach problems ( nausea , vomiting and loss of appetite ) have been seen in patients who received chemotherapy . tell your doctor or nurse immediately if you have continuing fever and chills . these may be signs of an infection ( rash ). tell your physician or nurse if you get any problems breathing , wheezing or any stomach problems . very common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in outer carton in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 25 ) for up to 6 hours . do this medicine if you notice any visible sign of deterioration . do
what mepact contains the active substance is mifamurtide . one vial contains 4 mg of mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg mifamate . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' mepacts contains lactose '), 2 - dileoylu - sn - glyco - 5 - sodium monosodium salt ( see also section 2 " mepACT contains lactate "). what
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin of the face to reduce redness ( rosacea ) and redness of theface . rosica is caused by high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels that supply the excess blood flow and red skin .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor or pharmacist before taking mirvasos : - if the medicine is injected under the skin ( subcutaneously ) - if your doctor has told you that you are taking certain medicines for depression or parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), t
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin ( usually on the face ) only . this medicine is not applied to other parts of the body . it should only be applied to body surfaces . avoid touching your eyes , mouth , nose or vagina . do not touch your eyes with your hands . if you use more mirvasos than you should if you have used more miraso than you have been told to , contact your doctor . if possible , show them the pack . if the doctor has changed your dose
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation or inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects are worsening of rosacea and the treatment should be stopped immediately . symptoms may occur within 2 hours of contact allergy . rare allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are given mirvaso stop using mirvasoa and tell your doctor immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with tube and pumps after first opening . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasoa contains methylparhydroxy benzoate "), propylene Glycol . what mirvasos looks like and contents of the pack mirvasoe
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body against infection and cancer . bevacsizumb binds to a protein called human vascular endothelial growth factor ( vegf ), which is found in lymph vessels all over the body . the vegfs protein is found on blood vessels where it stimulates them to grow and to supply blood vessels with oxygen . be vacizumsab inhibits
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . if you have any of these conditions , please tell your doctor before using this medicine . if your child is less than 6 months of age , you or the child is at an increased risk of developing holes in the
dose and administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . your doctor may increase your dose to 15 mg per kilogram of your bodyweight . your dose of the mvasis will be calculated by your doctor . you will be given mvasic every 2 or 3 weeks . the number of infusions you receive will depend on how you respond to treatment . your physician will calculate the dose you will need and will tell you how often
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : side effects that may occur during treatment with mvai are similar to those of chemotherapy . if you notice any of these side effects while you are being treated with mvvasi , tell your doctor straight away . allergic reactions tell your physician straight away if you have an allergic reaction including : difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side effects include
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 and below 30 . do away with
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumumab in 1 . 4 ml of 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active substances in bevackizumb in 1. 4 ml . each 16 ml vials contains 400 mg of of bevanacizumaab in 16 . 4ml of solution ( see section 2 ). the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children who are not able to take other medicines . it works by inhibiting the growth of refractory mantle cell cancer ( b - lymphocytes ) in your own white blood cells . tecartus contains the active substance " autologous anti - cd19 - transduced cd3 + cells ". mantle cell lipoma is a cancer that affects the immune system ( the body ' s natural defences ) and affects the number of b - cells in your blood . mantle cell lysisoma b - clocytes
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - are allergic or have had problems with white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 ) - are white blood cell - are receiving autologous use ( see " other medicines and tecartuses ") tests and checks of your lungs , heart , kidney , blood pressure , infection or inflammation of your cancer ( graft -
tecartus is made from your own white blood cells . your cells will be collected by a specialised healthcare professional . your own cells will then be given to you by a catheter placed in your vein ( a procedure call leukapheresis ). your white blood cell will then come back to your blood . the first dose of your blood will be given by a doctor or nurse . it will be taken into a vein over 3 to 6 hours . the number of your white white bloodcells will then multiply over 2 to 3 hours . medicines given before tecartus treatment ( lymphodepleting chemotherapy ) the modified white
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you get any side effects you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure with symptoms such as dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness , confusion , memory loss , disturbances of brain function including difficulty speaking ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the infusion bag in order to protect from light . the product contains liquid nitrogen equivalent to 150 mg / ml . this medicine contains genetically modified human blood cells and is essentially free of human - derived material . the vials are stored in a freezer at room temperature ( up to 36 ). do away with the vene
what tecartus contains the active substance is autologous anti - cd19 - transduced cd3 + cells . each patient - specific single infusion bag contains a dispersion of anti -cd19 car t cells equivalent to 68 cd3 cells per 2 ml of infusion , corresponding to a concentration of 106 cd3 / ml . the other ingredients are : anti - cd19 , sodium chloride , human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartub is a clear , colourless to pale yellow solution for infusion , supplied in an
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas , or gl
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you have : - blistering of the skin ( bullous pemphigoid ) januven is not recommended if you suffer from a disease of the pancreatreas called pancreatitis . - gallstones . - alcohol dependence . - very high levels of triglycerides ( a type of fat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg . you should continue taking this medicine until your doctor tells you otherwise . your doctor will tell you how many tablets to take . this medicine can be taken with or without food . your dose may be adjusted by your doctor if necessary . this is because certain other medicines can lower blood sugar . diet and exercise can help your body use
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing , stop
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents of the pack pink
xultophy works by reducing blood glucose . it is used to treat type 2 diabetes mellitus in adults . diabetes is when your body does not make enough insulin or the insulin that your body produces does not work as well as it should . this results in an increase in blood sugar . insulin degludec ( a long - acting basal insulin ) is used when your blood sugar levels are too high ( liraglutide is a type of glp - 1 ) and you cannot use insulin during meals . xultophy is used in combination with oral medicines for diabetes xultime is used with oral medications for diabetes
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if you have 39 diabetes . if you take a sulfonylurea such as glimepiride or glibenclamide . your doctor will adjust your sulfonylation dose and will monitor your blood sugar levels regularly . warnings and precautions talk to your doctor or pharmacist before taking xulturo if you suffer from type 1 diabetes mellitus or ' ketoacidosis ', a condition which occurs after you start taking xulinophy
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your dose to maintain your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultue for 8 hours . you can take xupophy with or without food . xultide is supplied in a pre - filled dial - a - dose pen . the dose counter shows the dose to be taken in steps of 1 step : - insulin degludec 0 .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common ( may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . this could be a sign of serious hypoglycaemia ( which may cause brain damage ). if you have low bloodugar , your blood glucose level may go up . see a doctor straightaway if you experience signs of low blood glucose ( see section " warnings and precautions "). hypoglycasemia ( see also
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : do not store above 30 . store at 2 8 for a maximum of 21 days . do away with xultophy once you have opened the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime in 3 ml solution . each vial contains 300 units of the active substance of insulin gludec 10 . 8 mg liraagluteide . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xultphil contains sodium "). what xultos looks like and
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ] and her2 [ erbb2 ]). erbb3 and her4 are proteins that are produced naturally in cancer cells . this medicine stops these proteins from working and kills cancer cells quickly . this product is used to treat cancer of the lung ( non - small cell lung cancer ). giotriff is used as your first treatment after prior chemotherapy treatment in patients with squamous type a who have not received prior chemotherapy therapy .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you suffer from side effects associated with lung inflammation ( interstitial lung disease ) if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking giotrinif if : you have liver problems if your dose is reduced . your doctor may need to do some liver tests before you start taking this medicine . you have a severe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this medication with or just after food . you may take this this medicine with or with food . if you take more giotrinif than you should if you have accidentally taken more than the prescribed dose of this medicine , contact your doctor immediately . if possible ,
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotrinib : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea ( see section 2 for more information on severe diarrhoee and fluid loss ). common ( might affect up in 1 in every 10 people ) low blood potassium . worsening kidney function . if you experience diarrhoeea or develop diarrhoeas , you should contact your doctor immediately . appropriate antidiarrhoeal treatment is recommended . antidiarhoeal medicine should be given
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinab . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotratif looks like and contents of the pack giotarif 20 mg film - coating tablets are white to off - white , round , biconvex ,
what orkambi is orkamsi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older . the active substance is a protein called f508del mutation . f508d is a cystic fibre conductance regulator ( cftr ) that is found in the lungs . the mutation causes an abnormal cftl protein in the body . lumacftor works by interfering with the normal cfttr protein . lumaconaftor works in the same way as ivac
do not take orkambi if you are allergic to lumacaftor or ivacaftOR or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . orkabi may affect the f508del mutation in the gene that produces f508d . talk to the doctor or nurse before taking , orkaban if you have liver or kidney disease . the dose of orkaman may need to be adjusted . abnormal blood tests of the liver may be performed before orkami is given . tell your doctor if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 6 to 12 tablets a day . your doctor will tell you how many tablets of orkambi to take . the dose may be adjusted by your doctor . the starting dose is one 6 mg tablet a day for the first 6 weeks . the maximum recommended dose for the 11 weeks is one orkammi 100 mg tablet once a day ( 2 tablets a morning ). this is divided into 2 equal doses . the total daily dose for this 12 - week period is one 12 mg tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate . if you are treated with ivacaftor , you may experience some of the following : serious side effects that may occur with orkyambi : raised levels of liver enzymes in the blood , which may be a sign of liver injury or pre - existing severe liver disease . the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin
what orkambi contains the active substances are lumacaftor and ivacaftir . orkammi 100 mg film - coated tablets each tablet contains either 125 mg lumacftor or 125 mg ivacftir . each orkamberi 200 mg film film - coating each tablet contain either 200 mg lumiacaftor or 250 mg iviacaftir ( see section 2 " orkabambi 100mg film - coat contains either 200mg lumacafor or 150 mg ivaceaftor "). orkmbi 200mg film film coating each tablets contain either 125mg lumiacft
what lynparza is lynparaz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping the growth of mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors cause death by stopping cancer cells from producing an enzyme that helps repair dna . what lynparz is used for lynparanza is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian cancer ). it is used when
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given lynarza . if you think any of these apply to you , tell your doctor or pharmacist before you receive lynparz . if any of those apply to your child , tell them before you start treatment with lynparze . low blood cell counts ( seen in testing ) low counts of red or white blood cells ( seen as a sign of low platelet counts ) see section 4
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of lynarza capsules are taken in combination with tablets . if you take more than one tablet of lynpalza per day , you may experience side effects of 8 mg . you should take the tablet by mouth once in the evening . if possible , take your tablet at about the same time each day . if necessary , you can take your tablets with or
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions including hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store any lynparza capsules in the original package in order to protect from light . after first opening , lynparZA capsules may be stored at room temperature ( up to 30 ) for a maximum of 3 days . discard any capsules that have been stored at the room temperature for longer than 3 days , and discard any that have not been stored
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white , opaque , hard capsule with " olaparatib 50 mg " imprinted on one side and " astrazeneca logo on the other . lynparze is available in packs containing 112 capsules or 448 capsules
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children over 14 years of age . the risk of overdose is similar to those described in the section " warnings and precautions " below . breathing problems and severe sleepiness may be some of the effects of an opioid overdose . if you have any questions about how nyxoids works or why this medicine has been
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose may be similar to those of an accidental overdose . if you use more nyxid than you should if you think you have used more than the recommended dose , contact your doctor or pharmacist immediately . if possible , use this nasal spray 2 to 3 times a day
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one spray once a day . 1 . use the spray on the shoulders , ears , breastbone , sternum or inside the ear . do not use more than one spray in a day and use it every day . 2 . avoid touching or sounds that are not being controlled . 3 . avoid using the nasal spray in the chest moving around the chest . if you hear breathing sounds or breath on the cheek , you should contact your doctor immediately . overdose may occur if you have
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms ( see section 2 , " warnings and precautions "). opioid drugs may cause symptoms such as fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone . - the other ingredients are : ( hydrochloride dihydrate ), trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a 0 . 1 ml clear , colourless to pale yellow solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . nyxid is available in a carton containing 2
what ovaleap is ovaleape contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sacs ( follicles ) in the ovaries , and in the production of sperm . it is produced by a immature egg cell . ovaleaps is used in women who are not ovulating and who are undergoing treatment with a medicine called " clomifene citrate " and who have not undergone assisted reproductive technology procedures ( procedures that help you to become pregnant ). it is
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if you think you may have large ovaries ( sacs of fluids that carry blood from the ovaries to the womb ) if ovarian cysts are growing out of control . if you experience unexplained vaginal bleeding . if there is cancer in your ovaries , womb or breasts . if any condition that makes normal pregnancy impossible such as ovarian failure in early men
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of this medicine is one injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you will usually receive this medicine for the first 7 days of your menstrual cycle . the medicine will be given to you at the same time each day . the recommended starting dose of the medicine is two 75 mg capsules ( two 150 mg capsules ) given once a day . you will normally receive this medication for the next 7 days . your doctor will decide
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may cause weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 rare ( may affect up to 1 in 10 , 000 people ) this type of reaction may occur after your ovaleop injection . tell your doctor immediately if you notice any of the following serious sideeffects in women lower stomach ache , nausea and vomiting . these may be the symptoms of ovarian
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . do this medicine if it is accidentally frozen . if frozen , it may be stored for a maximum of 3 days below 25 . do away with this medicine and keep it at room temperature ( not above 30 ) for no longer than 3 days . once the cartridge
what ovaleap contains the active substance is follitropin alfa . ovaleop 300 micrograms / 0 . 5 ml : each cartridge contains 300 microlitres ( 22 microgram ) of follitroin ala in 0 . 0 ml . ovalesap 450 microgram s / 0. 75 ml : one cartridge contains 450 microlitre ( 33 microgram) of follitonropin alpha in 0.75 ml . each cartridge containing 900 microliters ( 33 million microgram )) of follionropin Î± in 1 . 5ml . the solution contains 600 microgram ( 44 microgram
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ) and candidaemia ( a form of fun fungal illness caused by candida sp ). in non - neutropenic patients ( patients with abnormally low white blood cells count ) to prevent candida spots . infections caused by the fungus flu
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if taking any other medicines , including herbal medicines . the medicines listed below may affect the way voricoazole accord treatment works . 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used when treating mental illness ) quinidine ( used if you have irregular heart beat ) rifampicin ( used used to prevent tuberculosis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dose the dose will depend on your weight and the type of infection you have . the usual starting dose is 40 mg once a day ( one 40 mg tablet in the morning and one 400 mg tablet at 12 hours of rest ). this is given as a single dose once a morning ( one 200 mg tablet per day ) for 12 hours followed by a 12 hour rest period ( one 24 hour restperiod ) for 24 hours followed after 24 hours . your doctor may increase your dose to 200 mg once daily ( one
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , you should contact your doctor immediately . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice ( changes in blood tests of liver function ) and pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg voronazole ( as besilate ). each tablet of voricoazole accord 50 mg ( film - coated tablets ) contains 200 mg viriconazol ( as mesilate ) the other ingredients of vORiconazle accord 200 mg are : tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lact
mvabea is a vaccine to protect you against ebola virus disease in the future . adults and children from 1 year of age with ebola virus who are already vaccinated with a 2 - dose course of vaccinations , the other ingredients are : ebolairus disease : the zaire ebolavirus and filovirus . this vaccine contains the whole ebola viruses that cause you ebola fever disease . warnings and precautions talk to your doctor or nurse before you are given mvabeas . vaccinations are given as follows : zabdeno vaccine 8 weeks later after you have received mvabdena vaccine .
your child will receive the vaccination course . if your child has had a severe allergic reaction ( see section 6 . if you have a severe allergy reaction to an antibiotic called ' gentamicin ' or any of the other ingredients of the vaccine listed in section 6 ). if your baby has had such a severe reaction to any other vaccine injection . if the child fainted after the injection . warnings and precautions talk to your doctor , pharmacist or nurse before your child receives mvabea . if any of these apply to your child ( or your child is not sure ), please tell your doctor . if a child has a severeergic reaction
the dose of vaccine is given by injection into a muscle ( intramuscular injection ) in the upper arm or thigh or into a blood vessel . the recommended dose of vaccination is one dose of zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine will be given at the same time . the first dose of the second dose is given at least 8 weeks after the first . primary vaccination first vaccination with zab deno red cap vial ( 0 . 5 ml ) second vaccination with mvabdenos yellow cap vials ( 0. 5 ml ).
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth or swelling where the injection is given very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) feeling sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness or skin hardness where thejection is given generalised itching . the most common side effects are : common ( likely to affect up in every 1 in 100 people
what mvabea contains the active substance is zaire ebolavirus 29 produced in a recombinant dna technology by recombinant technology inactivated with tai forest ebolabirus nucleoprotein marburg ( rdna ) in 0 . 7 ml of solution for injection ( containing 108 strains of chicken embryo embryo fibroblast cells ). the other ingredients of this vaccine are trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvagaa is a suspension
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronat can also be used to prevent a raised calcium level in your blood due to a tumour . this helps to reduce the amount of calcium that is lost from your bones . it also helps to stop your bones getting weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - if there are low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT if you have a possible side effect called osteonecrosis of the jaw ( onj ), which can be severe and can lead to bone damage in the jaw . your doctor may decide to reduce your dose of bondronate if you suffer from cancer or related conditions . onj can be life - threatening and may be fatal . stopping
this medicine is given to you by a doctor or nurse with experience in the treatment of cancer . it is given as an infusion into your vein . your doctor will do regular blood tests before you are given bondronat . your dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , it may take 3 to 3 weeks ( including 3 - 4 weeks without an infusion in your vein ). this may take up to 15 minutes if you are having a raised calcium level in your blood . your usual dose is 1 mg / kg body weight once a day ( for example , 2 - 4 days
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 in 10 , 000 persons ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems called necrosis ( dead bone tissue ) in the jaw bone . ear pain or discharge
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). after dilution the infusion solution should be used within 24 hours . do this medicine if you notice particles in the solution or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack the concentrate for bondronate is a clear , colourless to pale yellow solution . it is supplied in a glass vial containing 1 ml or 2 ml of solution , with a bromobutyl rubber stopper .
what zeposia is zeposeia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zeposaia is used for zepoesia is given to adults with relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsitting remitting ms attacks on the nerve cells , causing the symptoms to disappear or for periods to be difficult to tolerate . some problems may be life - threatening . how zeposes
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred in the last 6 months . if any of these apply to you , tell your doctor . if your doctor has told you that you have irregular or abnormal heartbeats ( arrhythmia ). if your heart is not working properly after treatment . if the patient has severe infection such
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need and will work on your heart rate . your doctor may prescribe you a ' treatment initiation pack ' which is available in your pack . the first 4 doses are 0 . 23 mg ozanimod per day . the second 1 dose is 0 . 4 mg ozamanod per morning . the third 4 dose is 3 mg ozorod per afternoon . the recommended dose is to be taken once a day in the morning and
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure uncommon ( may effect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very rare ( may affects more than one in 10 , 000 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) and voice box ( larynx ). viruses
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0 , 46 mg :each capsule contains approximately 0 . 46 mg ozimod ( as hydrate ). ozanimood is also hydrochloric . ziposia 0. 92 mg : the active substances are approximately 0.92 mg ozamanod (as hydrate ), microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate
what temybric ellipta is temybaellipta contains two active substances called fluticasone furoate and umeclidinium bromide ( vilanterol ). fluticusone furaate belongs to a group of medicines called corticosteroids ( steroids ). umeleclidinnium bromeide and vilansterol belong to agroup of medicines known as bronchodilators . what temybarric elliptka is used for temyboneelliptka is prescribed to treat chronic obstructive pulmonary disease ( copd ). copd is a long
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric ellipte - if your child has asthma . warnings and symptoms talk to their doctor or nurse before using this medicine . some patients treated with temycbric elliptoe have had asthma . your doctor may need to adjust your dose of temybhric elliptea if your doctor has told you that your child
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more temy bric ellipte than you should if you have used more tembric ellipta than you have been told to use , contact your doctor immediately . symptoms of temybrexta may include a
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , stop taking temybric ellipta and seek medical help straight away . pneumonia ( infection of the lung ) in copd patients the most common side effect of temy bric elliptoe is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore or raised patches in the mouth or throat .
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umeleclidinnium bromeide and 55 microgram ( 23 microgram ) of umclidinia bromate and 22 microgram( 23 microram ) of vilansterol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' temy bric
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used to treat an infection of the lungs called ' pneumonia '. zzinforoe is used in adults . zin foro works by killing certain bacteria that cause serious infections .
do not use zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using zin foro if : you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). if this applies to you , tell your doctor before using this medicine . if you have kidney problems . you have ever had seizures ( convulsions ). you have or have had any non
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many doses to give . the recommended dose is one 600 mg dose every 8 weeks . if you have some infections that have not responded to your dose , your doctor may increase your dose to one 8 mg dose each 12 weeks . zin foro is given as a drip into a vein ( intravenously ) over a period of 5 minutes . your dose may be increased to 60 mg once every 120 weeks . your physician may decide to give you an increased dose . your course of treatment is 5 to 14 days . if skin infections
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects . if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . treatment with zinforo may be stopped or medicines stopped . slow bowel movement may affect up to 1 in 10 people . your doctor will do a blood test called a ' co
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections . what zinforto looks like and contents of the pack zinofo is a pale yellowish to light yellow powder for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin pumpfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with
do not take pregabalin pfizer : if you are allergic to pregagalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking preggabal pfiser . some patients taking pregaabalin pumpfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which could
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on how you respond to pregibalin psfizer . you should take pregaboralin pfeizer once in the morning and once inthe evening . if you weigh 59 kg or more , you should continue taking pregagalin pfingizer once
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , irritability . disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy . insomnia , fatigue , feeling abnormal . blurred vision , double vision . vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregaboralin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ), potassium hydroxide ( e433 ).
xadago is a medicine that contains the active substance safinamide . it works by increasing the levels of dopamine in the brain . dopamine is a chemical in the body that is important for movement . it is important that everyone in the family has a functioning brain , and is used to treat parkinson ' s disease . xadago helps to control parkinson ', a condition that causes sudden swings in the ability to move . people with difficulties moving can sometimes have problems with walking . xarmago is used in combination with the medicine levodopa , which is used with other medicines to treat the condition .
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any of : - monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , tranylcypromine . - if treatment for parkinson ' s disease or depression is not suitable . - pethidine ( a strong pain killer ). warnings and precautions talk to your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg twice a day ( 100 mg taken by mouth ) taken once a day . your doctor may prescribe a lower dose if you have moderately reduced liver function . the dose may be increased to 50 mg once a week . take xadadago at the same time each day . you should swallow the tablets whole with a glass of water . xadag can be taken with or without food . if you take more xadagon than you should if you accidentally take
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : hypertensive crisis ( very high blood pressure that may lead to collapse ) neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia , increase level of enzyme creatine kinase in your blood ) serotonin syndrome ( confused , hypertension , muscle stiffness , hallucinations , hypotension ). the following side effects have been reported with parkinson ' s disease in combination with safinamide and levodopa . they are usually mild to moderate and usually disappear after a few days . other medicines and x
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate and silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ). what xadag looks like and contents of the pack xadagus 50 mg film - coated tablets of 7 mm diameter with metallic gloss are white , round , biconc
zytiga contains a medicine called abiraterone acetate which is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the levels of testosterone in your blood when you have prostate cancer . ztiga is used in patients who have disease that has not responded to hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ) or who are taking another medicine containing prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the full amount of fluid from their blood .
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytigo if you have severe liver damage or prostate cancer . this medicine should not be taken with this medicine . if you know that you may have been given this medicine before , tell your doctor before taking this medicine if you : have liver problems such as high blood pressure , heart failure , low blood potassium . have low blood sodium . have heart rhythm problems or other heart
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 1 , 000 mg twice a day . you should take this tablet at the same time each day . this medicine should be taken by mouth . swallow the tablet whole with a glass of water . do not crush or chew the tablet . take zytiga at least 2 hours before or 2 hours after taking zytig . swallow your tablet whole . do this with a drink of water , preferably at the end of the day . do it at about the same times each day
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : - muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . your doctor may check your potassium more frequently . other side effects include : very common ( may affect more than 1 in 10 people ): - fluid in your legs or feet ( especially in the legs ), low blood potassium ( seen on liver function test ), high blood pressure , urinary tract infection , diarrhoea common ( might
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round tablets with a diameter of 9 . 5 mm . the tablets
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies are proteins that recognise and bind to other proteins in the body . addalimumab works by blocking the activity of a protein called tumour necrosis factor ( tnfÎ± ). the inflammatory diseases listed below are due to the inflammation
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis ( sepsis ), blood poisoning or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . if your / your child has moderate or severe heart failure . if you or your son has a serious heart condition . warnings and precautions allergic reaction allergic reactions may occur with symptoms such as chest tightness , wheezing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . your doctor may prescribe you a different dose of 20 mg or 40 mg once a week . your child ' s doctor may decide to increase the dose to 20 mg and 40 mg if your child is not responding adequately to the 40 mg dose . polyarticular juvenile idiopathic arthritis age and body weight how much to take adults , adolescents and children from 2 years of age weighing 30 kg or more 40 mg twice a day children from 6 years
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( which may occur up to 4 months after the last hefiya injection ): allergic reaction ( including heart failure ). severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre - charged syringe may be kept at room temperatures ( up
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiah 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear type
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dividing . how ritemvi works ritemvan is used for the treatment of a ) non - hodgkin ' s lymphoma . this is an illness of the lymph tissue that affects the immune system . it affects a type ( white blood cells ) called b
do not take ritemvia if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangitis or pemphigus vulgaris ( see section " warnings and precautions "). warnings and risks talk to your doctor before taking ritemvi if you think you have or
how ritemvia is given your doctor will decide how much ritemv you will receive and for how long . your doctor or nurse will watch you closely during this treatment . you will be given this medicine to reduce any side effects . how ritemva is given ritemrovia is administered as a drip ( intravenous infusion ). medicines given before each ritemvo administration you will take ritemra together with other medicines ( pre - medication ) to reduce the risk of side effects and to improve your response to your treatment . if you are being treated for non - hodgkin ' s lymphoma , you will first
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
what ritemvia contains the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each vial of concentrate contents contains 10 mg of the active ingredient in ritiximab ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemvi looks like and contents of the pack ritemitri is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine cheva is used to treat colon , rectal , gastric , or breast cancers . furthermore , capecitamide teva is prescribed to be used after the complete removal of the tumour by surgery . cape citabineteva may be used either alone or in combination
do not take capecitabine teva if you are allergic to capecitabanine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice before taking this medicine . if you have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) if you or your child are pregnant if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) if your child has severe liver or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva depends on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface area taken once daily . this is for example : a person whose body weight is 64 kg and height is 1 . 64 m has a body surface areas
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements each day . any diarrhoee at night may be severe . vomiting : if vomiting is severe . nausea : if your stomach does not empty as quickly as it should . if you lose your appetite . stomatitis : if pain , redness , swelling or sores in your mouth and / or throat . hand and foot skin
what capecitabine teva contains the active substance is capecitabiline . capecitibine tevas 150 mg film - coated tablets each film - coating contains 150 mg capecitobine . furthermore , capecitafine teeva 500 mg film film - coat contains 500 mg capecabine . the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hyproellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red (
silodosin recordati contains silodosino recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodousin recordat works by blocking signals to the prostate , bladder and urethra . this helps to maintain smooth muscle in these tissues . it also helps to reduce your symptoms . silosin Recordati is used to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordat : - if your child is undergoing eye surgery - if the child has cloudiness of the lens ( cataract surgery ) 26 - if he or she has been treated with silodocin recordatin before , or has been given medicine to prevent a loss of muscle tone in the iris ( the coloured part of the eye ). during a surgery , appropriate precautions are
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule taken once a day , with or without food , at the same time each day . you should take silodnosin recordat for at least 8 hours every day . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodosiin recordata is taken once daily , with with or with food , in the morning and evening , at about the same times each day
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives . the most common side effect of silodosin recordati is dizziness . dizziness may also occur with occasionally fainting . if you feel weak or dizzy , contact your doctor . the symptoms of dizziness and faints usually disappear within a few minutes . if they do not disappear within one hour , contact the doctor . if any of the symptoms causes dizziness or fainty , contact a doctor
what silodosin recordati contains silodosein recordat 8 mg : the active substance is silodofin . each capsule contains 8 mg silodnosin . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosiin recordatin 4 mg : silodosesin . 4 mg contains siliodosin . as the active substances are mannaitol , aluminium stearata , sodium lactilsulfATE , gelatin, titanium dioxide , yellow iron oxide ( e172 ). what silodosain recordi looks
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzal mono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzialmonio is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is less than 3 months old . - if the child is pregnant . warnings and precautions talk to your doctor or pharmacist before taking kinzalkalmonos ( see section " pregnancy and breast - feeding "). - if any of these apply to your child ( see " pregnancy section "). if your baby has severe liver problems ( such as cholestasis or biliary obstruction ) or problems with drainage of the bile from the liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed with some water . you can take kinzalmono with or without food . try not to take more tablets than your doctor tells you to . if you take more kinzdalmono than you should if you have accidentally taken too many tablets , contact your doctor immediately . treatment of high blood pressure the usual starting dose of kinzhalmono is 40 mg once
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : if you experience any of the following , seek immediate medical advice : sepsis ( often called " blood poisoning "), a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ), these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) cardiovascular events .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once your medicine has been taken out of your refrigerator , it must be used within one week . do this by referring to the new expiry day on the blister . do away with the blister that is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisar . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate . what kinzalao looks like and contents of the pack kinzalimono 20 mg tablets are white to off - white , round tablets with " pfizer " debossed on one side and " 20 " debottled on the other side . kinzalano is available in blister packs of 14 , 28 , 56
afstyla is a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa . afstylfa is used to treat bleeding episodes in adults with haemophilia a ( inborn factor v iii deficiency ). factor v ii is a naturally occurring component of blood clotting and is required to clot the blood . patients with an increased tendency to bleed have been shown to have higher levels of factor v viii than in patients with haophilia b . therefore , it is important for the blood to clot properly . afostyla has been shown in
do not use afstyla if you have had an allergic reaction to afstylea or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afstya . the dose and the batch number should be recorded in your treatment diary . do not use more afstlya than recommended if you think you may be allergic ( hypersensitivity ) reactions . warnings and symptoms of allergic reactions are listed below . allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphylaxis
your treatment will be overseen by a doctor experienced in blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the dose of afstyla you receive will depend on the severity of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be mixed before use to avoid aseptic conditions . afstlva must be used in combination with other medicines and solvents . see section 6 . the solution should be clear to slightly opalescent and
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure , dizziness and anaphylaxis ( bleeding ). in patients receiving factor viii medicines , inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). patients who have received previous treatment with factor v iii ( more or less than 150 days of treatment ), the risk of developing uncommon ( less than
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . do away with the vial and keep it in theouter carton to protect it from light and moisture . the
what afstyla contains the active substance is lonoctocog . each vial contains 250 iu ( 2 . 5 mg ) lonoectocog alfa . after reconstitution with 2 .5 mg of injections the solution contains 200 iu lonoCTocog aluminium . each 1000 iu vial provides one injection . after initial reconstitration with 2. 5 mg of water for injections the product contains 400 iu of lonoontocog alpha . each 1500 iu / ml vial provided one injection and one injection after the initial reconitution with 5 mg / ml of water
what praxbind is praxBind contains the active substance idarucizumab . idarucaizumb is a recombal agent . it is similar to dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what prax bind is used for praxbinding is used to rapidlytrap dabigATran . what it is usedfor ? prax binds to pradxa in adults . it may be used in emergency surgery or urgent procedures to stop uncontrolled bleeding .
do not use praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfid ). if this applies to you , tell your doctor . warnings and precautions talk to your doctor before using this medicine . serious adverse reactions have been reported with the use of praxBind in patients taking this medicine in combination with dabigatran . other medicines to prevent blood clots dabigitran is a naturally occurring substance in the body which helps to prevent formation of blood clumps . medicines to
the recommended dose is 5 mg ( 2 . 5 mg ) dabigatran per kilogram of body weight . this medicine is given once every 5 weeks . your doctor will decide the dose that is right for you . your dose will be decided by your doctor . your healthcare professional will decide how much dabigATran you need . this will be given to you over a period of 5 minutes . this is because this medicine will be injected into a vein . your treatment will be supervised by a doctor who is experienced in the treatment of blood clot formation . dabigadran will be administered to you 24 hours after you have been
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what praxbinding looks like and contents of the pack prax bind is a clear to slightly opalescent , colourless to slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap . each pack contains one vial .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and then together with monotherapy phase oftreatment . - in children 3 years of age and older and adult patients with malignant glioma , such as glioclastoma multipurpose or anaplastic astrocytoma . temarmac is given in combination
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing and swelling of the face , lips , tongue or throat . if any of these affects you severely , your white blood cell count and platelet count may decrease . these blood cells are important for fighting infection and for proper blood clotting . if you already have some of these cells in your blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . your doctor may also prescribe other medicines ( anti - emetics ) to help you tolerate temomedicine ( see section 4 ). if you experience nausea or vomiting , stop taking temomedacon and contact your doctor . if you currently have newly - diagnosed glioblastoma mult
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache , temomedac treatment may result in a reduction in certain kinds of blood cells . this may result , in cases , in increased bruising or bleeding , anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can lead to a severe form of anaemia ('
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with the capsules if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomedic 5 mg : each capsule contains 5 mg temozoleomide ( as mesolomides ). temomediac 20 mg :each capsule contains 20 mg temzolomine ( as temozomide ). temmedac 100 mg : every capsule contains 100 mg tem ozolomile ( as Mesolomid ). temarthac 140 mg : one capsule contains 140 mg temazolomice ( as besilomide ) ( as esilomid ) (as mesolomonide ). - temomedacon
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard erect penis suitable for sexual activity . cialis works by making a hard erection more comfortable for men . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works in the blood vessels of your penis to help your penis stay hard and erect . this helps to maintain erectile function . ceralis works on the blood walls of your erect penis . this will help to maintain erection throughout sexual activity and makes
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are taking organic nitrate or nitric oxide donors ( such as amyl nitrite ). - if any of these are medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali . if you have recently had a heart attack or within the last 90 days . - if recently had had a stroke in the last 6 months . - you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual dose is between 5 mg and 2 . 5 mg . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the doctor your pack of tablets . if necessary , show them the pack of cialitas . if more cials
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain ( frequency cannot be estimated from the available data ) nitrates ( frequency unknown ) priapsim may cause a prolonged and possibly painful erection . stop taking cialis and seek medical help straight away if you get an erection that lasts longer than 4 hours . contact your doctor immediately if you experience sudden loss of vision ( frequency is not known ). other side effects very common ( may affect more than 1 in 10 people ) uncommon ( may
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e 172 ),
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglide is used to treat type 2abetes in adults . treatment is usually started with diet and exercise and weight reduction . your blood glucose may be increased when enylid is taken in combination with metformin . if you have diabetes , eny glid
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your dose is too high . if any combination of eny glid or gemfabrozile ( a medication used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg once daily for 4 weeks . your doctor may increase your dose to 30 mg every 16 weeks . if you take more enylid than you should if you accidentally take too many enygelid tablets , or if someone else accidentally takes your medicine , contact a doctor or the nearest hospital straight away
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . however , some patients may experience hypoglycationemic unconsciousness ( coma ). allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects include : common ( may effect up
what enyglid contains the active substance is repaglinide . each 0 . 5 mg tablet contains 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablet and red iron oxide (< e172 ). only in 2 mg tablet what eny glid looks like and contents of the pack enylid 0 .
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine mylon is used for azacita mylan contains the active substance azacinidine . what it is used in adults azacacitine mylan has been prescribed for use in adults . azacuitidine myla is used after a stem cell transplantation in patients with higher - risk myelodysplastic syndromes ( mds ). it is also used in adult patients with chronic myelomonocytic leukaemia ( cmml ). it can also be used
do not use azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before using azacacitrix mylan : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has given you a heart condition ( such as heart attack ). - tell the doctor if you
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azaccitidine myl to give you . your dose of this medicine will depend on your height and weight . azacacitine mylan will be administered every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) by your doctor or nurse . it is given by subcutaneous injection ( subtype skin ) on the skin of your thigh , tummy or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( which may also be symptoms for kidney failure ). a fever , which may indicate an infection with low levels of white blood cells . chest pain , shortness of
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be used within 1 hour after preparation . the azacididine myla suspension must not be mixed with water for injections . thesuspension must be stored in a refrigerator ( 2 8 ) for 8 hours . the zacitine mylan suspension must also be stored with water and injections for 8 days after preparation , and stored in
what azacitidine mylan contains - the active substance is azacinidine . one vial of powder contains 100 mg azacita . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol . what azacididine myl looks like and contents of the pack azacitonidine mylon is a white powder supplied in a glass vial containing 100 mg of azacito . pack sizes of 1 and 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprost is a prostaglandin analogue in the eye . timololine is a beta blocker that reduces fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( e . g . wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever ). - tell your doctor if your baby has a slow heartbeat . - if he / she has heart failure ( a disorder of heart rhythm , irregular heartbeat ), or if the inside of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye once a day . do not use duotrav in both eyes . use duetrav in the affected areas only . do this if your doctor tells you to . do the same for your other eyes . do use duvetrav in all other eyes as recommended by your doctor . how to use dudoserav is provided in a pack containing 1 bottle of eye drops . each bottle contains 2 , 3 or 4 bottles . a bottle is also available for use in
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be kept in the bottle to help protect your eyes . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness . common side side effects these may affect up to 1 in every 10 people effects of duotroph of theeye surface inflammation or surface damage . signs and symptoms include eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signsand symptoms include : eye irritation , burning and stinging . uncommon side effects this
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg of travaprost and 5 mg of timolole . - the other ingredients are timololine maleate , polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg / ml . - ingredients in the solvent are : boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . what duotra looks like and contents of the pack
nplate ' s active ingredient is romiplostim . it is a protein that helps to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important as they help to protect the blood from blood clots . very low platelets can cause bruising and serious bleeding . nplate is used to treat adults , adolescents and children aged 1 year and older who have had their spleen removed or who have chronic itp . it may be used in patients who have
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking nplate : if you have a low blood platelet count ( thrombocytopenia ). nplate may reduce your platelet counts . if you suffer from blood clots . if blood clists are a problem for blood clotting . if any of these apply to you , tell your doctor . if your doctor has told you that you have liver problems .
nplate is given to adults and adolescents from 1 to 17 years of age . your doctor will decide how much nplate you need and how often you need to take nplate . nplate is administered as an injection under the skin ( subcutaneous ) over a period of 1 hour . if you have the impression that the effect of nplate too strong or too weak , talk to your doctor . how often to take and when to take your nplate your doctor may check your platelet counts . you will have regular blood samples taken to check your white blood and your platelets are in the normal range . your dose will be
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in10 people ): bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing , blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , indigestion
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . after first opening , use within 30 days . do away with the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains approximately 230 mg romiplustim . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each single - dose vial provides 125 mg of romipliplostime in a deliveredable amountof 0 .25 ml solution , delivering 125 mg / ml romiplOSTim . every two - dose ampoule contains 500 mg romoplostim and each single dose vials contains 375 mg romclostim ( 250 mg / l ). each single treatment
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on copd .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - tell your doctor if you have kidney problems - tell him if you develop an eye problem called narrow - angle glaucoma ( difficulty passing urine ) during treatment with tovannor breezer . if you experience any of these effects , stop using this medicine and seek medical advice immediately . - tightness of the chest , coughing ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhalation each day . you should inhale this medicine at least 24 hours before or at least 75 hours after a meal . you can use this dose at any time of the day . do not use this leaflet if you notice that the content of the pack is changed . how to use this medicinal product is provided as an inhaler and capsules ( in blisters ). the medicine is inhaled using inhalation
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyroniumbromide and 50 microgramS glycopylronium . the delivered dose ( the delivered amount that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopYRronium per inhale . - the other ingredients of the inhale powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezker 44 microplastic
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are important for calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms ( such as schizophrenia ) hearing , seeing things which are not there , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . the most common symptoms of bipolar disorder
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvet ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms such as wheezing , shortness of breath , lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortnessof breath ( see section 25 " warnings and symptoms "). if you suffer from neuroleptic malignant syndrome ( nms ), which may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day , taken in 2 hours and 4 . 5 hours . if your condition worsens , your doctor may prescribe a lower dose . adasuve is for oral use . you should take adasuves with food . it is best to take adasve with a meal or snack at the same time each day . you can take adamsve with or without food . you may find it easier to take it with or just after a meal . it may
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have any of the following side effects : any breathing symptoms , such as wheezing , cough , shortness of breath , chest tightness , irritating , or irritating , that may be caused by your airways ( asthma or copd ). light - headedness or fainting . your blood pressure may be increased , worsening agitation , confusion , fever and muscle stiffness . these may be signs of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more than 1
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use adasve if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxapeine . after dilution , each single dose delivers 4 . 5 mg loxide . what adasuves looks like and contents of the pack adasuva 4 . 0 mg is a white to off - white plastic inhaler , imprinted with " loxpine " on one side and " nvr " on the other side . each inhaler is packed in a sealed foil pouch . adasuvel 4 . 4 . 95 mg is available in packs containing 1 or 5 inhal
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent . it belongs to a group of medicines called ' anti - metabolites '. what azaccitidine betaparm is used for azac citidine betafarm is for use in adults . azacacitrix betapharms is used in adults who have not had a stem cell transplantation and who have certain higher - risk myelodysplastic syndromes ( mds ), chronic myelomonocytic leukaemia ( cmml ), acute myeloid leukaemic ( aml ).
do not use azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before using azacacitrix betapham : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has given you a heart condition ( such as heart attack or lung disease ). blood
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azacita betapham you need . your dose of this medicine will depend on your height and weight . azaccitidine betafarm is given every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( which may also be symptoms for kidney failure ). a fever , which may indicate an infection with low levels of white blood cells . chest pain , shortness of
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . any unused azaccitidine betabarm must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be used within 45 minutes . the azacididine betafarm suspension must not be mixed with water for injections . thesuspension must be stored in a refrigerator ( 2 8 ) for 8 hours . the zacitine betapham suspension must also be stored with water and injections for 8 days . the product must
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azacinidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol ( e421 ). what azacididine betafarm looks like and contents of the pack azacnitidine betabarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacito .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . when eliglustate is taken with glucoslceramide , it causes your affected organs to relax . your doctor will test for this before you start taking this medicine . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . if any of the above
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 or moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are used to improve your body ' s ability to absorb nutrients . warnings and precautions talk to your doctor before taking cerdelg . cerdelgas should not be used in patients with medicines known to be a poor metaboliser .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day with food . the amount of metaboliser that you need depends on how much you weigh . the dose of metabolizer that you take is one 84 mg tablet twice daily . swallow the tablet whole with a glass of water . if you take more cerdelga than you should if you accidentally take too many tablets , contact your doctor immediately . to open the blister / wallet , remove the sleeve , and press down with your thumb or your finger on the blister . open
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgas
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the back bone ). to reduce the amount of calcium in the blood in adult adult patients where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . do not use zoledron acid hospir - if you are allergic ( hypersensitive ) to zoledor acid , another bisphosphonate ( the group of substances to which zoledoral acid belongs ) or any of the other ingredients of zoledicle acid hospire ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using zoledric acid hospiral : - if any of these apply to you , tell your doctor before using it .
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ). this is called ' iv ' administration . you must drink plenty of fluids before and during treatment with zoledronic acidic hospira , and for at least 4 hours afterwards . if you have a kidney problem , your doctor may decide to lower the dose depending on your kidney problem . zoledron acid hospir is also used to prevent bone complications caused by bone metastases . how zoledic acid hospire is given your doctor will decide how much infusion of zoledicle acid hospita you
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain blood tests ) low level of calcium in the blood uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness in the jaw , and loosening of a tooth . these could be signs of bone damage in the g
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ).
what zoledronic acid hospira contains - the active substance is zoledron acid . one vial of zoledrine acid contains 4 mg zoledrin acid . - the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledicle acid hospire is a liquid concentrate for solution for infusion (' sterile concentrate ') which is supplied in a glass vial containing 4 ml of zolingronic acid . each pack contains one vials of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . these nerve cells are important in helping your body fight against cancer . they help your body to fight against the cells that cause nausea and vomiting . when you feel sick , rolapit works by stopping these nervecells from working properly , helping you fight nausea and / or vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if your doctor has prescribed varubry for you . if you have depression or difficulty sleeping ( see section 2 " warnings and precautions "). if you think any of these apply to you , tell your doctor before taking this medicine . warnings and risks 27 if you suffer from severe liver or kidney problems . if your dose of certain medicines ( e . g . rifampicin ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with a glass of water , about 2 hours before your chemotherapy cycle . you can take varuby with or without food . if you take more varubys than you should if you have taken more varubsy than you have been told to , contact your doctor straight away . if possible , show them the pack . if necessary , show the pack of tablets . if sickness occurs , show it to your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect more than 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , and he or she may decide to stop your treatment . other side effects include : very common ( may affects more than1 in 10 people ): headache constipation feeling tired uncommon ( may effect up to
what varuby contains the active substance is rolapitant . each tablet contains 90 mg rolapit . the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubry
what enerzair breezhaler is enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and the active substance glycopyronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the lungs and makes breathing easier . what enerzary breezcheler is used for enerz air breezer is for inhalation use
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzaire breezcler if : you have heart problems , such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures you have severe kidney problems you have or have had severe liver problems you suffer from low level of potassium in your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . the medicine should be inhaled once a week . use enerzair breezhaler every day , at the same time of the day . this will help you to get the best results for your asthma and reduce your symptoms . use in children and adolescents use in adolescents and adolescents is the same as for adults . use with enerzaire breez inhaler in adults . how to use enerzeair breezezhalER is provided as an
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side side effects include the following side effects : very rare ( may affects more than1 in 10 , 000 people ): sore throat , runny nose , sudden difficulty breathing , feeling of tight
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used within one week after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacataterol as acetates , 63 microgram of glycopreyronium bromides , 50 microgram glycopyronium , 160 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram indacate , 58 microgram ( glycopirroniumb
clopidogrel acino pharma gmbh contains the active ingredient clopidagrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmÃ¡ gmbhl is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of clopidineogrel agabilate ( see section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopidiogrelacino pharmÃ¡ gmbhl . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopidineogrel aclara gmbhl per day to be taken orally with or without food . you can take clapidogel acino piogrelacino pharmh with or just after food . if you take more clopidoogrel agrogrogrogh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) rare ( affects less than 1 users in 1 , 000 ) rare : very rare ( affecting 1 to10 users in 10 , 000 ). very rare : not known ( frequency cannot be estimated from the available data ). contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplogrel aclarica pharma if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ), crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmÃ¡ gmb h looks like and contents of the pack clopideogrel acc
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are taking medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine ( which is a nucleosideride analogue reverse transcriptases inhibitor ( trti ). tenofovir disoproxil ( a nucleositide analoguereverse transcriptase inhibitors ( nrti ) and delstrigo . delstriga is used in adults to treat and prevent hiv infection in adult
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if your doctor has told you that you are taking any of : - the following medicines : carbamazepine , oxcarbazepine ( medicines to treat tuberculosis ) - st . john ' s wort ( hypericum perforatum , a herbal remedy used for depression and anxiety ) - products containing mitotane ( a
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of a single tablet once a day for hiv infection , taken at least 1 hour before or at bedtime . your doctor may prescribe you certain medicines ( such as doravirine ) to help you remember to take your tablets . medicines that lower the amount of this medicine swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . taking this medicine take delstigo once a morning , at about the same time each
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion and suicidal thoughts 45 trouble concentrating memory
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ) the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumar . a coating material containing carnauba wax e903 , hyprogellose , iron oxide yellow ( e172 ), lactose monohydrate
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression . it also helps to reduce the symptoms of depression , such as feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant , which is also used in children and adolescents ( aged 2 years and older ). there are many different types of antidepressant medicines .
do not take spravato - if you are allergic to esketamine or any of the other ingredients of ketamine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out ) or bleeding in the brain . - if recently had a heart attack . within 6 weeks of taking spravat , you may experience a temporary increase in blood pressure . serious complications in these conditions can occur , and spravo should not be given to you . tell your doctor before taking this medicine if you have a heart problem , such
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the spravato nasal spray should be used immediately after you have been given it . the nasal spray device should be connected to the nasal pump device for 1 to 2 hours . there are 3 nasal spray devices connected to one nasal spraydevice for 4 hours . you should use spravat for 2 hours after you had been given this medicine . if you experience nausea or vomiting after 2 hours of treatment , you should continue treatment for 30 minutes after you received this medicine , as instructed by your doctor . nasal spr
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected from things and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch in the mouth area spinning sensation vertigo vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy , euphoria ( feeling agitated ), feeling anxious , eyes , ears , sense of touch are altered or mimicked irritable panic attacks change in perception 37 feeling , hearing , seeing or
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution for use in children . spravata is available in a single - use nasal spray unit . spreamato is available as packs containing 1 , 2 , 3 or 6 nasal spray devices
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . it can be caused by cancer that has a change ( mutation ) in a gene responsible for producing melanoma cells . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if you think any of these apply to you , tell your doctor or nurse before using zelberaf . allergic reactions if allergic reactions occur while you are using zezboraf , tell the doctor or hospital pharmacist immediately . if any symptoms of an allergic reaction occur , including swelling ofthe face , lip or tongue ), difficulty breathing or rash
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for up to 8 weeks . your doctor may increase your dose to 4 mg twice a day if you experience side effects . your treatment may need to be adjusted . taking zelboraf with food and drink you can take zelberaf with or without food . swallow the tablets whole with a glass of water . do not crush , chew or break the tablets . if you take more zelbaf than you should if you accidentally take too many tablets ,
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you experience any of the following symptoms : radiation treatment if you have any of these , tell your nuclear medicine doctor immediately . zelbaf treatment may cause radiation to affect the skin , esophagus , bladder , liver , rectum , and lungs . tell your radiation doctor immediately : if you develop any of any of your following symptoms , including skin rash , blistering , peeling
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this after the first opening of the blister . do away with the blister if you notice that the blister is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). the other ingredients are hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelbearingaf
duoplavin contains clopidogrel and acetylsalicylic acid ( saa ). it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels expand . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events , which can lead to stroke , heart
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic , but are not sure , talk to your doctor or pharmacist before taking duoplin if any of these apply to you . warnings and precautions talk to you doctor or nurse before taking this medicine if you : are allergic , or have previously used other products called non - steroidal anti - inflammatory products . if you have painful and / or inflammatory conditions of muscles or joints .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have had a heart attack , take the tablet as soon as you remember . if possible , take your tablet with you and then go to your nearest hospital emergency department . if bleeding occurs , stop taking duoplain and contact your doctor immediately . if more
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 mg of the active substances , clopidogrel , acetylsalicylic acid (asa 75 mg and clopipidogel , hydrogen sulphate ). each 75 mg tablet contains acetylSalicylicacid , mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil . see section 2 ' duopllin contains hydrogenatedcastor oil ' for further information . the other ingredients are stear
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonididine tartrates belongs to the group of medicine called alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . simbrinz is used to treat pressure in the eyes in adults aged 18 years and older who have been previously treated for eye conditions such as glaucoma , ocular hypertension and high pressure in their eyes .
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you currently take certain antidepressants , or if you previously take any antidepressant medicines . if you suffer from severe kidney problems if you retain too much acidity in
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid touching the affected eye or eyes with your hands . step 1 step 2 step 3 step 4 step 5 step 6 step 7 step 7 remove the cap and snap collar . hold the medicine with your fingers . twist the bottle , pointing down . pull down the lower eyelid with a clean finger and insert a ' pocket ' between the eyelid and the eye . the drop will go in here . step 6 steps 1 step 4 steps 5 step 7
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat tell your doctor immediately if you experience extreme tiredness or dizziness . the other side effects that have been reported with simbrinza are : common side effects ( may affect up to 1 in 10 people ) effects in the eye ( allergic conjunctivitis
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . if you use more simbrinza than you should if you accidentally use too much simbrinusza , tell your pharmacist or nurse straight away . you may get infections or a new bottle . do this if you notice any change in the appearance of the tablets . do
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brinza and 2 mg of of brimonine tartrate equivalent to 1 . 3 mg of Brimonidine . the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified water , hydrochic acid and
filgrastim ratiopharm contains the active substance filgrastam . filgrasterim is a protein produced by biotechnology in bacteria called escherichia coli . it is similar to a natural protein ( granulocyte - colony stimulating factor ) produced by your own body . filfilgrasteric stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgnastim allows your body to produce more white blood cells quickly . filgrimastim ratiopharm will be given to you in combination with
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgrateim ratitarm ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using filgratim ratisopharm . if you have a cough , fever and difficulty breathing , tell your doctor straight away . this may be a symptom of a pulmonary disorder . if any of these apply to you , tell the doctor straightaway . possible side effects if you get sickle cell disease 57 if you feel left upper abdominal pain or
how much filgrastim ratiopharm is given your doctor will decide how much filgnastim ratiopharm you will receive . how often filgrateim ratisopharm will be given your dose of filgrasterim ratiasopharm depends on : how often you will have filgrasteim raticoopharm treatment . filgrustim ratioopharm in combination with chemotherapy is usually given as 0 . 5 mg once a day for 60 days . however , you may be given up to 30 mg once daily during your treatment and for 14 days afterwards . some disease types may be more
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder . see section 4 . if you experience any of the following side effects , your doctor may order regular blood tests before you are given filbrastim ratiopharm . neutrophils ( a type of white blood cells ) are important in determining the number of cells in your blood . your doctor will test your blood before and during treatment . other medicines and filgrasteim ratisoph
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrateim . each ml of solution for infusion contains 60 mg of filgrasteim . filgrasterim ratisopharm 30 mg / 0 . 5 ml : each pre - filled syringe contains 30 mg filgracyim in 0 . 05 ml . filgnastim ratiopharm 48 mg / 1 ml : one pre -filled syringe containing 48 mg filgnacyim . - the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol , polysorbate 80 and water for
what riluzole zentiva is riluxole zenta contains riluuzole which belongs to a group of substances called ' neurotransmitters ' which are involved in the nervous system . what rilzole zsentiva is used for rilizole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ) motor neurone disease ( ms ). ms affects the nerve cells that carry nerve signals to and from the muscles , causing weakness , muscle waste and paralysis . ms is caused by the destruction of nerve cells . motor neurONE disease may also be caused by too much glutamate (
do not take riluzole zentiva if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). if you have any liver disease . if you experience increased blood levels of some enzymes of the liver called transaminases . if this applies to you , tell your doctor before taking rilzole zenta . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have anyiver problems . if yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick ( which may be
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the tablets should be taken by mouth once a week . the maximum recommended dose for adults is 12 tablets once a morning . if you take more riluzole zentiva than you should if you accidentally take too many tablets , contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zenta with food . if a child swallows some tablets , it may be a problem to take the tablets with food
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check white blood cell counts and may adjust the dose if necessary . infections tell your doctor if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do
what riluzole zentiva contains the active substance is rilusole . the other ingredients are : - core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white to off - white , round and marked with ' 50 ' on one side and ' ril ' on the other side . the tablets have a diameter
emgality contains the active substance galcanezumab , a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which patients have increased levels of cgrm . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older . migraines are a common symptom of migraine . emmality can reduce the frequency of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases can lead to allergic reactions emg abnorm may cause serious allergic reactions . these reactions may be life - threatening . see section 40 for signs of a serious allergic reaction . if you notice such signs , tell your doctor straight away . you may be more likely to get side effects as described in section 4 . children and adolescents emgally is not recommended for children and teenagers under the age of 18 years . other medicines and
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 240 mg injection once daily . emgally is given under your skin ( subcutaneous injection ). you may receive your emgalis injection with or without proper training . if you have been given more emgals than you should if you think you have received more emgsality than you have needed , tell your doctor straight away . if more emmality than has been given to you , tell the doctor or nurse immediately . if a dose is missed or if you forget
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash , raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , the product can be stored for up to 7 days at room temperature ( up to 30 ). do this medicine if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . - the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the solution is clear to slightly yellow . the syringe is supplied in single - dose pen packs of 1 , 2 or 3 pre - fill pens
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hav ) in which the blood vessels in the liver become damaged and blood clots form . it can be given to you in combination with medicines you have received prior to a stem cell transplantation . defibrorotide works by helping the blood arteries to open and close , so that the blood clasts can form . if you have any further questions on the use of this medicine , ask your doctor or pharmacist .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if you take medicine to prevent bleeding ( for example , if you get heavy bleeding after a blood transfusion or surgery ). if your doctor has told you that you have problems with blood circulation ( a constant blood pressure ) if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before using this medicine . warnings and
the treatment with defitelio will be started by a doctor who is experienced in the treatment of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . the duration of this treatment is 21 days . if your symptoms do not improve after this 21 day period , your doctor may decide to reduce the dose . if you have any further questions on the use of this medicine , ask your doctor or pharmacist . children and adolescents do not give this medicine to children under 18 years of age . if a child swallows some of the medicine , contact
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine and in the mouth bleeding from under the skin coagulopathy ( disturbance in blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon (
keep out of the reach and sight of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do do not put defitlioio near heat or in the sun . do use defilitelio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect
what defitelio contains the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibroide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections . see section 2 " defitelsio contains sodium ". what defitELio looks like and contents of the pack defiteloio is a concentrate for solution for infusion . it is supplied in a 10 ml glass vial containing 2 . 0 ml concentrate .
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c , an infectious disease that affects the liver , caused by the hepatitis c virus . this medicine stops the hepatitisc virus from multiplying in your body . it also prevents the virus from spreading to other parts of your blood . daklinz is used in combination with other medicines to treat and prevent hepatitis c infection . the other medicines that you will be taking with daklineza are : - tablet - tablet combination - tablet tablet combination combination - combination combination daklonza with other medicine to treat or prevent hepatitisc infection .
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with any of your following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to treat epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to prevent tuberculosis ) dexamethasone ( a steroid used to correct allergic and inflammatory diseases ) medicines containing st . john ' s wort (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this dose once a week . do this twice a day to avoid unpleasant taste . your doctor may tell you to take dakinza with some other medicines . if you take more daklanza than you should if you have taken more duklinza than your doctor tells you to , contact your doctor . if possible , take these medicines as directed by your doctor , and then take your daily dose
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when taking daklineza in tandem with sofiosbuir and ribaveirin the following other side effects have been associated : common ( likely to affect up in every 1
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of
proquad is a vaccine to protect against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the body ' s own immune system ( the body Â´ s natural defences ) will produce antibodies against the measles , rubles , mites , rubell and varicelluses . the antibodies help to prevent diseases caused by these viruses . proquad is used to prevent measles , measles , and rubella with chickenpox (" varicelli ") in adults 12 months of age and older . pro quad is used in children and adolescents 9 years of age or older
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder or type of cancer that affects the immune system ( e . g . treatment with medications that weaken the immunesystem , e . e . low - dose corticosteroid therapy , asthma or replacement therapy ) if your child has a weakened immune system due to a disease ( including aids ) if he / she has congenital or hereditary immunodeficiency ( immune competence ) if the child has active
proquad is given by injection into the muscle ( subcutaneous ) or under the skin ( usually in the thigh or upper arm ). injections will be given into the upper muscle ( usually the thigh area ) or upper upper arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . injecting under the surface of the skin may reduce bleeding and therefore proquad should not enter into the blood vessel . proquad is injected under the foreskin ( subtype ). proquad can be given to infants and children from 9 months of age and adolescents from 12 years of age with
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur . if these reactions occur , you may have difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) and a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side effect that have occurred with pro quad include : very common
what proquad contains the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryl Flynnâ¢ level b ) strain , 4 . 30 mg rubella virus2 , strain , 6 . 00mg varicella virus3 , merck strain , 9 . 99 mg mrc . the other ingredients are : tissue culture : plaque - forming units ( mrc ), 1 type of chick embryo cells , fibroblasts ( mcc ). powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate ,
jylamvo is an anticancer medicine that reduces unwanted reactions . it is an immunosuppressive agent . it acts on the body ' s own immune system to suppress its own immune activity . jylamv is used in adults to treat rheumatic and skin diseases : - active rheumatoid arthritis ( where the polyarthritic forms of the joints are absent ) - severe juvenile idiopathic arthritis ( jia ) in children 3 years of age and older . it can be used alone or in combination with non - steroidal anti - inflammatory drugs ( nsaids ) to treat inadequate o severe or
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 if you know that you may have a weakened immune system if you think you have or have ever had a serious infection such as tuberculosis or hiv if you develop ulcers in the stomach or intestines ( an inflammation of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will determine the dose you need and will adjust the dose depending on your condition . the treatment is usually started in the following groups : rheumatoid arthritis severe juvenile idiopathic arthritis severe psoriasis severe psoriatic arthritis jylimvo is used as a long - term treatment . jjlamvo is also used in the treatment of rheumatic and skin diseases ( jia , psor
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching on the whole body . other side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry stools
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from light . the medicine must be used immediately in case of accidental spillage . the vial is stable for 3 hours at 25 . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotroxybenzoate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzzoate ( e218 ), sodium methyl parahhydroxybenziate (e218 ), citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl paraahydhydroxy benzoate and sodium methyl paraahhydxybenzozoate "). what j
what enurev breezhaler is this medicine contains glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to improve the quality of life for
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has given you an eye problem called narrow - angle glaucoma ( difficulty passing urine ). warnings and precautions talk to your doctor or pharmacist before using treatment with enurevo breez inhaler . if you have any of these conditions , stop using this medicine and contact your doctor immediately : - tightness of the chest , coughing , wheez
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at a temperature of 75 to 75 Âºc . you can use this medicinal product at any time of the day . do not use this product if you notice that the capsules are not clear or have particles in them . how to use this leaflet is provided in the pack ( enurev breezhaler inhaler ). the medicine is provided as inhalation powder . the capsules should be swallowed whole
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing dizziness allergic reaction ( swelling mainly of the tongue , lips , face or throat ) angioedema ( see section 2 ). other side effects include some sideeffects listed below ( frequency cannot be estimated from the available data ): common side effects ( may effect up to1
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyroniumbromide equivalent to 50 microgram of glycopreyronium . - the delivered dose ( the delivered amount that leaves the mouthpiece of the inhaler ) is 44 microgram glycopirronium per inhale . - - the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurevo breezker 44 microlitre
riximyo contains the active substance rituximab , a " monoclonal antibody ". this is a type of white blood cell that attaches to a target in the body . when ritukimab sticks to the target , it stops the cell from growing and dies . riximyo is used for the treatment of several different conditions . ruximyo can be used in adults with : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue . it affects the immune system ( the body ' s natural defences ) and affects a type a of white bloody
do not use riximyo if you are allergic to rituximab , other proteins that are similar to ritonuximib or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before using rixima if you : have granulomatosis , polyangiitis , microscopic polyangitis or
how much riximyo is given your doctor will decide how much ricoi you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may decide to change your dose . rixima is given as a drip ( intra - venous infusion ). medicines given before each riximusyo administration you will be given rixamyo together with other medicines ( premedication ) to reduce the risk of side effects . your doctor can adjust the dose of your treatment depending
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of the active ingredient in ritiximab , 10 mg per ml . the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixima contains sodium "). what rixamyo looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion . it
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat small cell lung cancer that has not responded to chemotherapy or advanced cervical cancer that cannot be treated with surgery or radiotherapy . in this case topotican actv treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan activ . your doctor will check your blood cell counts if they are too low . your dose of topotican actv may need to be adjusted . - if your doctor has told you that you have any kidney problems . your treatment with topotchean actez should be carefully supervised . warnings and risks talk to the doctor or nurse before using this medicine if any of
your doctor will determine the dose of topotecan actavis you will receive based on the disease and on results of blood tests carried out before treatment . the usual dose for treatment of adults small cell lung cancer : 1 . 5 mg per square metre of body surface area for 5 days . this treatment cycle will be repeated every three weeks . cervical cancer : 0 . 75 mg per sq metre of surface area , for 3 days . your doctor will decide how long you will be treated . thistreatment cycle will also be repeated each year . for cervical cancer , the usual starting dose is 0 .75 mg per cubic metre of the body
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . your doctor may need to adjust your dose or stop your dose . your general condition may include local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections and lung inflammation ( rare , may effect up to 1 in 1 ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 to 8 , when stored in a refrigerator ( 2 to 9 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) and glucose 5 mg /
what topotecan actavis contains the active substance is topotecaan . 1 ml solution for injection contains 4 mg of topotan ( as hydrochloride ). after reconstitution 1 ml contains 1 mg of the active ingredient of topetecan . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotican actis looks like and contents of the pack topottecan actiks are white to off - white , round , bromobutylic stopper and aluminium seals with plastic flip - off caps
the active substance of rivastigmine hexal is rivasterigmine . rivastersigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasta works by blocking the enzymes that break down acetylchloroline : acetylchelinesterases and butyrylcholinescerase . by blocking these
do not take rivastigmine hexal - if you are allergic to rivastaigmine ( the active substance in rivostigminehexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction ( allergic contact dermatitis ) with rivustigmine . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking this medicine . - if any member of your family has a history of irregular or slow
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg twice a day . your doctor may also increase your dose depending on your weight . your dose will depend on how well you respond and how well your medicine is working for you . if you take more rivasta hexal than you should if you have taken more rv
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects that have been reported are : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may affects up to1
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . store in the original package in order to protect from moisture .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 95 mg of rivostigmine . each vial of each ritastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each ri . each
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) and liver cancer when the patient is already taking a specific anticancer medicine containing sorafenib . what cabometyx does cabometx works by blocking the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking these proteins , cabometometyx can kill cancer cells .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety : - if your doctor has told you that you have high blood pressure - if the doctor has given you an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - if diarrhoea has been reported - if , in recent instances , you have significant bleeding from surgery within the last month - if any of these apply to you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the correct dose of this medicine and will adjust your dose depending on your response to your treatment . this will be in case you experience serious side effects . your dose may be adjusted or treatment stopped . the recommended dose of cabometyx is 60 mg once a day . you should take cabometx for 2 hours before or after food . you can take cabometricyx with or without food . it may take up to 1 hour before or without drink . swallow the tablet whole with a glass
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor straight away if your side effects become severe or persistent . if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea ), feeling sick ), vomiting , constipation , fever . these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood ,
what cabometyx contains the active substance is cabozantinib ( s )- malate . cabometx 20 mg : each tablet contains cabozatinib_( s ) - malate equivalent to 20 mg cabozanib . cabobometyx 40 mg : every tablet contains cozanthinib (s ) - Malate equivalent of 40 mg cabzantinab . cabostyx 60 mg : the active ingredient is cabuzantinip ( s ). each tablet also contains malate , and is supplied in a 60 mg / 60 mg film - coated tablet . the other ingredients are :
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pememetrexing hospira also will be administered in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will decide if pemetrixed hospiera is suitable for you if you have lung cancer at an
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are not suitable for breast - feeding . during treatment with pemetemetrexED hospira , you may be given a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospir if you have or have had problems with your kidneys . before you receive pemetrixed hospire , you will have an infusion of some of your blood (
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will use this body surface area to work in exactly the right way . your dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetemetrexED hospira will be given to
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash , burning or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : chemical and physical in - use stability of the product has been demonstrated for 24 hours at refrigerated temperature . the reconstitution solution should be used immediately . parenteral medicines : if you notice discolouration prior to administration , this medicine should be disposed of in accordance with local requirements .
what pemetrexed hospira contains the active substance is pemetre . pemetresed hospiras 100 mg : each vial contains 100 mg of pemetereed ( as pemetreted disodium hemipentahydrate ). pemetemetrexED hospira 500 mg : one vial of 500 mg contains 500 mg ofpemetrexes ( as pyrexed dis sodium hemipertahydrates ). pemrexedospira 1 , 000 mg : the active ingredient is pemexed . pemxed disdisodium hemimeentahhydrate is excret
what ganfort is ganint contains two active substances called bimatoprost and timolol . both help to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work together by blocking a prostaglandin analogue . timolole belongs to medicines called beta - blockers . what ganFort looks like and contents of the pack ganit is a clear , watery liquid that is injected into the eye by your eye . ganat is used in the treatment of glaucoma in adults . genfort eye drops are used to
do not use ganfort eye drops : - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( signs include wheeziness , difficulty in breathing , and long - standing cough ) - warnings and precautions talk to your doctor or pharmacist before using this medicine - if the child has coronary heart disease ( symptoms include chest pain , tightness , breathlessness , choking ) - heart failure - low blood pressure
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use treatment the bottle is for single use only . the bottle should be put in the neck . how much to use 5 . 1 . wash your hands . do not touch your head . 2 . pull down your eyelid , which is covered by a small pocket . 3 . gently squeeze the bottle , until the inside of your eye has completely closed . if you use more ganf than you should if you have used more ganedfort than you have been told to , contact your doctor
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause some side effects when taken with ganart ( multi - dose or single - dose ). very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side side effects these may affect up to 1 in 9 people ( 100 patients ) the effect of ganat is : - sensitivity to light - eye pain - sticky eyes , dry eyes - feeling of something in the eye - small breaks in the surface of the eye ( inflammation ) - difficulty in seeing clearly - redness and itching
keep out of the reach and sight of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . if ganf is accidentally frozen , it must be used immediately . if you notice that the solution is not clear and contains particles , it should be discarded after 4 weeks . do this and return the product to the refrigerator . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / 0 . 5 ml ) timolol maleate ( 6 . 8 mg / ml ). - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly yellow , clear , colourless to slightly brown solution for injection in the eye . ganf
gefitinib mylan contains the active substance gefitinib . this protein is designed to recognise and kill cancer cells . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefinibmylan if : you have any other lung problems . some lung problems may get worse while you are taking gekitininib yourlan . you have problems with your liver . gefnitinib is not recommended for use in children under 18 years of age . other medicines and gefilitinib tell your doctor or pharmacist if you take ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you should take the tablet with food . you can take antacids on an empty stomach ( see section 2 , " gefitinib mylan contains lactose "). take the tablets at least 1 hour before or 1 hour after food . gefnitinib melan can be taken with or without food . if you have trouble swallowing the tablets , you can crush them and mix them with any other liquids . the total recommended daily
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting your body . the signs
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - in the tablet coating are polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan looks like
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can be a low red blood cell count ( anaemia ) and can be caused by lack of red blood infusion . reblozey is used : to treat anaemia in adults with mds who cannot receive red bloodcell transfusions ( erythropoietin therapies ) in patients with beta - thalassaemia . thalasmaemia
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor before taking this medicine if you have thalassaemia ( a condition where the spleen removed ) or have had a blood clot . if you receive hormone replacement therapy after a previous blood clot , your doctor may recommend preventive measures ( including medicines used to prevent a blood clot ). if any of these apply to you ( or you are not sure ), talk to a doctor or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests to make sure that you are fully hydrated . how reblozyl is given rebl ozyl is an injection under the skin . the injections should be given in a hospital setting . the recommended dose is 1 . 0 mg / kg of body weight . your dose may be adjusted by your doctor if needed . your physician will adjust this dose depending on your blood pressure . how much reblzyl you will receive in patients with myelodysplastic synd
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions with rashes 36 if you get any side effects talk to your doctor . very common side effects ( may affect more than 1 in 10 people ) chest infection difficulty in breathing or shortness of breath
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 hours when stored at 2 8 . do away with any unused medicinal product or waste material . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution , each ml contains 50 mg of the active ingredient luspatecept . the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack reblizyl is a white to off - white powder . reblazyl 25 mg powder for solution for
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer by stopping it from multiplying . it also prevents the growth and spread of cancer cells by blocking new blood vessels . fotivada is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told that you have a condition called " hypericum perforatum " ( a herbal remedy used for depression and anxiety ). warnings and precautions talk to your doctor or pharmacist before taking fotiveda if any of these apply to you . high blood pressure tell your doctor if you think any of this applies to you , or if you feel any of your symptoms are getting worse . fotivada will not lower your blood pressure . your doctor will
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day ( 21 capsules ) for 7 days followed by 1 day ( 28 capsules ) in total for 4 days . do not take more fotvda than your doctor tells you to . if you experience unacceptable side effects or severe side effects , stop taking fotiva therapy and contact your doctor . the usual dose of the fotive tablet is 890 mg once daily ( 21 days ), followed by 7 days ( 28 days ) (
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( this side effect can occur in more than 1 in 10 people ) tell your doctor immediately if you experience any of the following : high bloodpressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high blood hypertension is often treated with a medicine to treat your high blood blood pressure . if you take more fotv
what fotivda contains the active substance of fotive is tivozanib . each tablet contains 890 mg of tivzanib ( as tiv ozanib hydrochloride monohydrate ). the other ingredients are : tablet core : 890mg tivuzanib , mannitol ( e421 ), magnesium stearate . capsule shell : gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( titanium dioxide , e171 ). tartrazine aluminium lake (
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of elvitabine ( an antiiretroviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil ( an antiviral medicine named a nucleotide reverse transcriptases inhibitor ) stribild is given as a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection in adults . stribil is used
do not take stribild - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking stribil . during treatment , your doctor may tell you to stop taking any medicine containing tenofovegravira . this is based on your kidney function and should be avoided . if you have previously taken any of these medicines , tell your doctor . - alfuzosin (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age : take the tablets 35 once daily by mouth . swallow the tablets whole with a glass of water . you can take your tablets with or without food . your doctor may change the dose of your medicine or interrupt the treatment if you take medicines ( oral supplements , antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ). see section 4 for further information . if you forget to take stribild if you miss
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the hiva disease itself or by other medicines you are taking . serious side effects tell your doctor immediately if you experience lactic acidosis ( excess
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtritabine , 245 mg tenofovegravor disoprocessil , 300 mg ten ofovir dissoproxel fumarate , 136 mg tenor . the other ingredients are tablet core : croscarmellose sodium , hydroxypropyl cellulose , lactose mon
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypyxa . zypitxa has not been studied in elderly patients with dementia . serious side effects have been reported
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken once a day . your doctor may increase your dose to between 5 mg and 20 mg once a week depending on your symptoms . swallow the tablets whole with a glass of water . do not chew or crush them . zzyprexa can be taken with or without food . you should take your zypxa tablets at the same time each day . it is important that you take your tablets at least one hour before or one hour after food . zchyprexa
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( a side effect which may affect more than 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . zyprexa should be used immediately after dilution . do this if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypxa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg of olanza . the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are marked with the following symbols : - zypoxa 2 . 4 mg , 6 mg , 7
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that attaches to another protein in the body . this protein is important in preventing bone loss in patients with osteoporosis . treatment with prolia helps to make bone stronger and keeps it free of oestrogen . it reduces the amount of oesterrogen that makes bones break down , and helps to prevent bone from becoming thin and fragile . what osteopORosis is osteoporeosis is caused by the lack of enough of a female sex hormone called testosterone . when osteopoorosis is not treated , it can
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor straight away . if any of them apply to your child , tell them straight away and tell your pharmacist . warnings and symptoms talk to their doctor or nurse before using this medicine : if you develop a skin infection with symptoms such as a swollen , red area of skin in
what prolia is prolia contains one pre - filled syringe of 60 ml , which should be given every 6 weeks . it is given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . you can inject prolia with or without stickers . you may also be given a single injections under theskin ( subcoveraneous ) either in the upper thighs or abdomen or in the lower arm . if you use more prolia than you should if you have used more prolias than you have been told to , tell your doctor or pharmacist . if possible , you may
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolium : swollen , red area of skin , usually in the leg , which feels hot and tender . symptoms may include fever . stop using prolia if you experience pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), as these could be signs of bone damage in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . before you use your pre - filled syringe , you may remove the cap from the vials and store it at room temperature ( not above 25 ) for a single period of maximum three months . after the injection , you can store your pre- filled syringes at room temperatures ( not below 25 ) or below 30
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab ( 60 mg / ml ). - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirox is a vaccine used to protect adults from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus is caused by the virus in faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . you may feel sick , have a fever , aches or pains , feel very tired , have dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to person . all
you must not be given ambirix if you are allergic to ambirux or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before you are given ambira if you : have hepatitis a or hepatitis b diseases if you get a severe infection with a high temperature . the vaccine should be given at the same time every week .
your doctor or nurse will give you ambirix as an injection into a muscle in the upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . the first injection will usually be given at least six months after the second injection . the second injections will usually come between 6 and 12 months after . if you miss an appointment for the first dose , you should make another appointment as soon as possible . if it is more than 12 months since the first overdose , you may be given extra doses
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired or irritable pain and redness where
what ambirix contains 26 the active substances are hepatitis a virus ( 1 , 720 micrograms / ml ) and elisa units ( hepatitis b surface antigen ). the other ingredients are 20 microgram ( 0 . 5 ml ) human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe is a white , slightly milky liquid . ambirous is
what bexsero is bex serumo is a meningococcal group b vaccine . what bex sero is used for bexsa is a type of vaccine that contains the bacteria neisseria meningitidis group b . bexservedo is given to adults and children from 2 years of age with disease caused by the neisser meningitsidis groupb bacteria . these bacteria are very sensitive to the effects of the vaccine and can cause infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your body
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex serumo if : you have a severe infection with a high temperature . vaccination should be postponed until you have recovered from a minor infection such as a cold . vaccination of patients with haemophilia a if you have any other problem that may prevent your blood from clotting properly . you are receiving blood thinners ( anticoagulants ) as part of treatment for the immune system ( eculizumab ). if you think you
your doctor or nurse will give you bexsero at least 5 minutes into the injection into the muscle of the thigh or upper arm . injections will be given at least 2 weeks apart . the first injection will be administered at least one month apart . after the first dose , the second injection will usually be given between 2 and 5 weeks apart ( see section 2 ). if you miss three injections , your doctor will give the vaccine as an additional injection ( booster ). the first interval between injections will usually last between 2 to 3 weeks . if you stop the injection , your physician will give your child an additional booster . children and adolescents from
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness of the area of the injection at the area where the injection is injected . other side effects may occur with this vaccine : common ( might affect up to 1 in every 10 people ) fever , loss of appetite , tenderness around
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitis group b noada protein 1 and 2 , 2 and 3 50 microg protein recombinant neoisseria meingitidas group b fhbp fusion protein 3 and 4 , 2 or 3 50 micromole / ml recombinant noisseria pleasenitidis type b f hbp fusionprotein 3 and 3 , 3 or 50 micromolecules recombinant non - recombinant eisseria
nitisinone mdk contains the active substance nitisinONE . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hdk ) in adults , adolescents and children from 1 year of age . in this disease your body does not make enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisine stops tyrosinone from working properly and helps to remove the harmful substances from your body . this means that tyrosaline is eliminated from your system by low tyrosines , such as phenylalanine ( another amino acid ).
do not take nitisinone - if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone mdk is not recommended for use in pregnant women . your doctor will check your eyes before and during nitisinaone treatment if you develop red eyes . if you notice any problems with your eyes , tell your doctor immediately . your physician may recommend an eye examination . if any of these apply to you , tell the doctor . eye problems due to inadequate dietary
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once a day ( approximately 20 mg / kg ). in this patient population , the dose may be increased by taking or reducing the number of capsules taken orally . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone than you should if you accidentally
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . do away with the blister if you notice a temperature below 25 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitis inone mdks 2 mg : each capsule contains 2 mg nitisine . nisinone dk 5 mg : one capsule contains 5 mg nisine . each capsule of nitishinone mdky 10 mg : two capsules contain 10 mg ninone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitisinnone mdku looks like and contents of the pack nitisinetone mdyk capsules are 15 . 7 mm long , hard
docetaxel accord contains the active substance docetaxal . docetxel belongs to the group of anti - cancer medicines called taxoids . docelaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : for the diagnosis of advanced breast cancer : docetacel could be administered either alone or in combination with doxorubicin , or trastuzumab , or capecitabine . for the prevention of early breast cancer with or without
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if your number of white blood cells is too low - if this applies to you - if if you have a severe liver disease . warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacel accord . if you experience white blood cell disturbances , such as fever and infections , tell your doctor immediately . if abdominal
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( mÂ² ) and will determine the dose you should receive . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your healthcare professional will take care of your blood tests and will adjust the dose depending on your generalcondition . in particular
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be higher when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store below 25 . store in the original package in order to protect from light . do away with the vial once it has been opened . after dilution , the medicine should be transferred from the infusion bag to the infusion vial within 6 hours ( corresponding to 25 minutes of infusion ). the infusion solution should be used immediately . non - pvc bags may be stored for 48 hours at 2 to
what docetaxel accord contains - the active substance is docetacel . each ml of concentrate for solution for infusion contains 20 mg docetamine . each 1 ml of the concentrate contains 20mg docetaceel . one 4 ml of each concentrate contains 80 mg docel . the 8 ml vial contains 160 mg docnetaxel . - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetagel accord is a concentrate for ethanol "), citric acid anhydrated ( see " docel accord and ethanol "). what docetAXel accord looks
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . this medicinal product works by reducing the activity of an area called ' dopamine ' in the brain called dopamine . this means that dopamine is released from dopamine receptors in the body and dopamine is activated when dopamine is stimulated . this stimulation reduces the amount of dopamine released by the body . intuniv is used to treat adults who have an increased level of dopamine in their dopamine system after a few weeks of current stimulation . this reduces adhd symptoms . the medicine is used in combination with a treatment programme
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intuniframus : if you have low or high blood pressure if you suffer from heart problems if you know that you have heart problems , or if you fainted recently if you had thoughts or feelings of suicide or any other psychiatric conditions ( withdrawal symptoms ). if you notice increased heart rate or highblood pressure while taking this medicine , stop taking this medication and talk to a doctor straight away . this is because you may
your treatment will be overseen by a doctor experienced in the treatment of adolescentbehavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be gradually increased depending on how you respond to treatment . the dose will usually be 0 . 05 mg / kg of bodyweight once daily , but your doctor may increase your dose to 0 . 12 mg /kg of body weight once daily depending on your response to treatment and on how well
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , you should take your medicine and continue to take it as before . serious side effects tell your doctor straight away if you notice any of the following side effects : feeling drowsy ( feeling dizzy ), hypotension ( slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect with high blood pressure . symptoms include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these side effects occur , tell your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within one month after first opening of blister pack . do this if you notice any change in the appearance of the tablets . do away with the tablets after this time period . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine . each extended - release dose contains 2 mg of Guanfacin . each long - release treatment contains 3 mg of the active substances ( guanfuine ). each extended prolonged -release dose contains 3mg of guinfacine . every extended -release treatment contains 4 mg of of guanofacine ). the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povid
ecalta contains the active substance anidulafungin and is used to treat adults and children from 1 to 18 years old with a type of fungal infection affecting the blood or other internal organs ( invasive candidiasis ). ecalta works by preventing the infection by stopping the growth of fungo - fungal cells called candida . it is used in combination with echinocandins . these medicines prevent serious fungal infections caused by fungal cell walls . ecaltera is used when fungalcells have incomplete or defective cell walls , which may make them fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra if you have liver function problems . your doctor may decide to reduce the dose you receive , or stop your treatment , or to give you anaesthetics . your treatment with ecaltas may need to be stopped if you develop an allergic reaction such as itching , wheezing , blotchy skin . an infusion related reaction may
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . adults ( aged 1 to 18 years ) the recommended starting dose is 3 . 0 mg / 200 mg given twice a week , with a maintenance dose of 1 . 5 mg / week . the dose may be increased or decreased depending on the patient ' s weight . ecalta is given as a slow infusion ( a drip into a vein ) lasting 1 . 4 to 3 hours . the loading dose will depend on the infusion size and the patient '. your doctor will calculate your treatment over a period of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): - low blood potassium ( hypokalaemia ), diarrhoe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 . if the infusion solution is not used within 25 hours it should be stored in a refrigerated
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of aniduafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( hcviii ). the human coaggulation factor iii is produced by recombinant dna technology . factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is not produced in the body . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by
do not use adynovi - if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is allergic to any of these ingredients . warnings and precautions talk to your doctor or pharmacist before using adynov : - if the child has had an anaphylactic reaction ( a severe , sudden allergic reaction ) to adyni . allergic reactions may include rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing ,
treatment with adynovi will be started by a doctor experienced in the treatment of haemophilia a . always use adynov exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment of bleeding your doctor will decide whether adynova is suitable for you . the replacement therapy with adnovi is a life - long treatment . always take this medicine exactly as described in this leaflet and as your healthcare professional has told your doctor . check the box at the end of this leaflelet for further information . prevention of bleeding the recommended dose of adynoc 40 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath , wheeezing or tightness around the chest ( feeling ofbeing unwell ), dizziness or loss of awareness , severe symptoms may include difficulty in blinking or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a maximum of 3 days . do this medicine if it is accidentally frozen for a single period of less than 3 days , but it must be kept in the refrigerator at room temperatures (
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu of ruriorioctoctocag alfa pepegol . the solvent vial is also supplied with 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) am
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ). they are produced by the ovaries and are responsible for the creation of many egg sacs .
do not use this medicine if you are suffering from your fertility problems . if you think you may be allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus if you develop enlarged ovaries or cysts on your ovaries if you suffer from polycystic ovarian disease ( bleeding from the vagina at an early menopause ) if there are malformations of the sexual organs ( which may or may not be caused by pregnancy ) if your womb contains fibroids of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will also prescribe anti - MÃ¼llerian hormone to stimulate your ovaries to produce more stimulation with gonadotropins . the dose will depend on the amount of hormones in your blood . your dose will also be calculated from your body weight . your physician will take a blood sample during the last 12 months to work out the dose you need . the total number of doses you need will depend upon how much rekole treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that cause infertility have been reported . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen . nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you experience any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation sensation ) pelvic pain and discomfort ( ovarian origin tiredness and fatigue ) uncommonly
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store at room temperature ( up to 25 ) for a single period of up to 3 months . after this period , the product may be stored at room temperatures ( up up to 28 ) for up to a maximum of 25 days . after the treatment any unused solution must be discarded . do away with medicines that are no longer
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of of follitonropin delta in each millilitere of solution ( corresponding to 0 . 35 ml of solutions ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water for
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptone contains flutic asone furaate and 92 mg vilancerol . the 22 inhalations of fluticusone fureate and 184 mg vilterol are 92 / 22 inhalation . chronic obstructive pulmonary disease ( copd ) in adults and adolescents ( 12 years of age and older ) weighing 184 kg or more : 184 / 22 adults and adolescent with chronic obstructative pulmonary disease or copd in adults . asthma in adults is a common form
do not use ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using ellipta . do not use revinty ellipta if any of these apply to you . if you have liver disease , tell your doctor straight away if you notice any of your side effects . if any patient has moderate or severe liver disease . the lower strength of revintchy ellipta 92 / 22 mg is recommended for patients with heart problems , high blood pressure , tuberculosis (
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhaler of fluticasone furoate and 22 mg vilanterol ). for severe asthma , the higher strength inhaler is one spray of flitantasonefuroate twice a daily ( one spray in the morning and one sprayin in the evening ) and one inhalant of 22 mg ( one tablet in the afternoon ). for copd the recommended starting dose for copdi is one
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), feeling very wheezy or coughing , difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ) immediate breathing difficulties immediate breathing problems stop using revinty ellipta and contact a
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of flutic asone firoate and 22 microlitre of vilancerol and trifenatate . each 184 microgramS inhalation provides 184 microliters of flilitasonefuroate , 22 micrometre of Vilanterl and trignenatatate respectively . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is a powder for concentrate for solution for
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ), tenofovir , a nucleotide reverse transcript enzyme ( ntrti ). these active substances are used in combination with antiretroviral medicines to reverse the action of an enzyme ( reverse transcriptasing ) that the virus needs to copy . atripla is a treatment for human
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach ( 1 to 2 hours apart ). some side effects may be more common , such as dizziness and drowsiness . if you take more atripola than you should if you accidentally take too many atriblea tablets , contact your doctor immediately . if possible , take your tablets with you . at the same time each day . you may need to take efaviren
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and seek medical help immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriblea film - coated tablet contains 600 mg efavairenz and 200 mg emtrixitabide and 245 mg tenofnovir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "). the tablet film coating
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . it is a synthetic version of the natural gonadodotrophine releasing hormone ( gnrh ), which is produced naturally in the body . when the release of gonadotroprophins from the follicle is stimulated by follicle stimulating hormone ( foll ), gonadots play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells and live in the follicles
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ) or any other gonadoteh - like hormone ( ngrh ) - if your doctor has told you that you have a moderate or severe kidney or liver disease . - if , for any reason , you are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions may be signs of an active allergic condition . your doctor will do additional
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is given to you by a doctor who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), corifollitropin on day 2 or day 2 of each 3 cycle . orgdalutran should be injected under the skin ( subcutaneously ) once a week for 5 to 6 cycles . your doctor will decide how long you should be treated with orgaluchran
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after a few days to a few weeks ( see section 4 ). uncommon ( may affect up to 1 in 100 people ) headache nausea ( malaise ) rare ( may affects up to one in 10 , 000 people ) allergic reactions such as rash facial swelling difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , which may cause difficulty in breathing or swallowing ( ang
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). syringes should be clear , colour - free solutions . do away with any unused syringe . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix ( 0 . 5 ml ). - the other ingredients are acetic acid , mannitol , water for injections ( for the ph ), sodium hydroxide and acetic acids . what orgaluitran looks like and contents of the pack orgaluchran is a clear , colourless aqueous solution for injection . the solution is clear and colourless . it is for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgalustran is available in packs containing 1 or 5 vials . not all
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type in a white blood cell called " b - lymphocyte ". when ritukimab sticks to this target , the cell dies . what blitzima used for blitzima can be used in adults with : a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue ( part of the immune system ) that affects a type called " white blood cells " ( b - cells ). blitzima
do not use blitzima - if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe active infection . - if he / she has a weak immune system . - warnings and precautions talk to your doctor or pharmacist before using blitzima if your baby has severe heart failure or severe uncontrolled heart disease . - granulomatosis , polyangiitis , microscopic polyangitis or pemphigus vulgaris ( see section " warnings and risks "). warnings
how blitzima is given your doctor will decide how much blitzima you will receive and for how long . always use this treatment exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor may decide to change the dose of this medicine or stop it altogether if you experience any side effects . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). it is given to you by a doctor or nurse who is experienced in the use of medicines similar to this . each blitzima administration will be individually administered to you . you will be treated with blitzima in
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of plate
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml solution . each 50 ml vials contains 500 mg of the active ingredient in ritiximab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is available in 2 strengths : 50 ml and 1 glass vial . not all pack sizes may be
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain called interleukin - 6 ( interlek ) and blocks the activity of this protein . this helps to reduce the inflammation in your body . roactemrea can cause symptoms such as pain and swelling in your joints . roactoremra reduces the damage to the cartilage and bone in the joints caused by the disease . roacticemra is used to treat moderate to severe active rheumatoid arthritis ( an autoimmune disease
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactemnra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness or light - headedness , swelling of the lips or skin rash . tell your doctor immediately if you notice any of these . infection tell your healthcare professional if you get infections or feel unwell . roactezra may affect your body ' s ability to fight infections . tell the doctor if
the doctor or nurse will give you roactemra by infusion into a vein ( intravenous infusion ). your doctor or a nurse will supervise the intravenous infusion and will decide on the treatment you need . the recommended dose of roactlemra is 8 mg / kg body weight . the usual dose is 4 mg /kg body weight once a day . the dose of rifampicin is 8mg / kg ( body weight ) once a morning . the daily dose of difampiccin is 30 mg / kilograms body weight twice a day for 12 weeks . the maximum dose is 30mg / kilograms (
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the following frequencies ( see section 3 ): stop taking roactemnra and see a doctor straight away : serious side effects ( may affect up to 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity ( may occur
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the outer carton and the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 ml . each 10 ml vials contains 200 mg of of tocelizumumab as 20 ml solution . each 20 ml vray contains 400 mg of the active substances of tocizumb as 20 mg solution . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack ro
what onbrez breezhaler is onbrezer contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . what onbreez breez inhaler is used for onbreza breezcheler is prescribed to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine relaxes these muscles in your lungs , making it easier for air to get in and out of
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using onbrezer : - if this medicine has been prescribed for you by your doctor , tell the doctor or nurse before using it . - tell your doctors immediately if you get tightness of the chest , coughing , wheezing or breathlessness immediately after
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day ( one 300 microgram ) day . your doctor will tell you how many capsules to use . your dose may need to be adjusted depending on how you respond to the treatment . your inhaler will be used 24 hours after you last used it . onbrez breezhaler is for inhalation use . you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . the onbreez bree
what onbrez breezhaler contains - each onbreez breez inhaler 150 micrograms inhalation contains 150 microlitres of indacaterol . - the other ingredients are indacataterol maleate , lactose and the capsule contains gelatin . - eachonbrez bronzhalzer 300 microgramsis inhalation provides 300 microlitre of indiacaterol as indacate . - printing ink contains lactose , lactoly and the capsules contain gelatin . what onbrex breezeler looks like and contents of the pack onbrezy breezer 150 - microgram
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel hcs - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your bleeding is not being controlled with adequate water or if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if severe liver disease is a problem . if any of these apply to you , tell your doctor before taking clopridogrel ccs . warnings and precautions take special care with clopIDogrel clcs if any part of you is at risk of bleeding such
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). the other ingredients are ( see section 2 ' clopide hcs contain hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and mac
feccroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously treated with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have ever had a severe allergic reaction to certain antibiotics ( e . g . penicillins or carbapenems ). if this happens , contact your doctor immediately . if you experience severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , stop
this medicine is given by a doctor or nurse as an infusion ( a drip ) into a vein . it is usually given every 3 weeks . it may be given every 2 weeks . your doctor will decide how often you should receive fetcroja treatment . your dose will depend on the type of infection you have and on the severity of your infection . you should not experience any pain during the fetcroJA infusion . it will be given into a separate vein . if you have kidney problems tell your doctor . if kidney problems are not treated , your doctor may decide to reduce your dose of fetcroj . if your dose is reduced ,
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions with difficulty swallowing or breathing . if you have this reaction , you may have diarrhoea , stools , blood or mucus , which may be very common . treatment with medicines to slow bowel movement may also cause this reaction . other side effects include : common ( may affect up to 1 in
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefirocol . - the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojoe is a white to off - white powder for concentrate for solution for infusion . it is available in packs containing 10 vials .
depocyte is used to treat adults with lymphomatous meningitis . lymphomastous menenitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared by biotechnology in the laboratory . it is used when lymphoma tumour cell cells have spread to the surrounding tissues .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking depocyte and contact your doctor immediately . taking any dexamethasone tablets may increase the risk of unwanted effects . if your side effects are not well controlled , or if you
before starting treatment with depocyte , your doctor will decide on the dose you need to receive . if you have cancer , your surgeon will decide the correct dose . depocyte will be prepared by injection in a laboratory or a healthcare professional . depocytes will be given to you by a doctor or nurse trained in the use of injections . the recommended dose is 1 to 5 g of dexamethasone per 5 ml of solution . each depocyte dose will be monitored by your doctor to detect any side effects . the dose of depocyte depends on the body surface area ( temperature ) and on the quantity of the product being prepared .
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ): very rare cases ( affects fewer than 1 to 1 user of 10 , very rare ) not known ( frequency cannot be estimated from the available data ): very common adverse events when depocyte is
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte may be stored at room temperature for up to 4 days in the refrigerator . do this to protect from light . do do not remove depocyte from the refrigerator after this time period . do so if you notice severe discolouration or a changed appearance . do away with the vials . do discard the
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytarabiline . each 5 ml vial contains 50 mg cytabine ( as cholesterol , triolein ). - the other ingredients are dioleoylphosphatidylcholine , dipalmitoylophosphatylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . it is supplied in a 5 ml glass vial as a single injection . each pack contains one vial .
what bemrist breezhaler is bemist breez inhaler contains two active substances called indacaterol and mometasone furoate . indacatorol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs . this makes it easier for air to get in and out of the lungs and makes it less likely that it will get in . momet asone fruate belongs to the group of medicine called corticosteroids ( steroids ). corticostromes reduce the swelling and irritation ( inflammation ) in the
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be allergic . - if any of these apply to you , tell your doctor before using bemrid breez inhaler . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems - diabetes - have high blood sugar - have seizures - have a low level of potassium in
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be used every day . you should use the medicine every day , at the same time of the day . this will help you to remember to use it . do not change the dose or stop using it unless your doctor tells you to . if your asthma is getting worse or your symptoms get worse , your doctor may prescribe bemended breez inhaler . how bemist breezhaleer is used bemrid breezheer is a kit
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling mainly of the upper tongue , the lips , face or throat ( angioedema ). other side effects other sideeffects include the following listed below : very rare ( may affects more than1 in 10 ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original blister in order to protect from light . do this after the first opening of the bottle . do away with the cap after this date . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ), mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single inhalation each contains 173 microgram indacate , 150 microgram of indacatesol and 80 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 125 microg / 62. 5 microlitre . each delivered dose (" momet ") is 150 microg/ momet
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherostrombotic events ( such as stroke , heart attack , or death ).
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions before you take zllt , tell your doctor if any of these apply to you . if any part of you is not sure , talk to your doctor or pharmacist before taking zylltt . if : you have an increased risk of bleeding such a medicalcondition that puts you at risk of internal bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zyllts contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the film - coating and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in thefilm - coating . what zyll
lamivudine teva contains the active substance lamivudrine . lamivudaine tella is used to treat long term ( chronic ) hepatitis b infection in adults . lamibine tevo is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamlivudineteva reduces the amount of hepatitis b in your body , and so causes a reduction in liver damage and
do not take lamivudine teva - if you are allergic to lamivudaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamividine tevas , like other similar medicines , can cause serious side effects , including liver disease and hepatitis c . if you become overweight , your doctor may need to change your dose . your doctor will do blood tests before you start your medication and regularly during treatment ( see section 4 , " warnings and risks "). if you take more lamivuine tella than you should if you have taken more lamidine than you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor lamivudine teva is used to treat your hepatitis b infection . it is important to take it every day until your infection is gone . it may be necessary to take a smaller dose if your illness remains largely unchanged . your dose of lamivuda teva will depend on how well you tolerate lamivodine teeva . your physician will prescribe lamivuine tevas for you if you have problems with your kidneys . your healthcare professional will prescribe you lamivubine in combination
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . the most serious side effects reported during therapy for hepatitis b are listed below . the side effects that have been observed during lamivudaine clinical trials include tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting and diarrhoea . increases in liver enzymes ( seen in tests ). the levels of enzymes in the muscles may be increased . allergic reaction ( rare , may affect up to 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be used immediately after first opening . do this if you notice that the tablets are damaged or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivuda . each film - coated tablet contains 100 mg of lamivu . - the other ingredients are microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - coat : 32 lamivodine tevas is supplied
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms are fatigue , weakness and shortness of breath . nespo contains the natural hormone erythropoietin . erythroietin works by blocking the action of erythrombocytopenia , which helps your kidneys to produce more red blood cell cells . it is also used to reduce the production of darbepoetin alfa in patients with chronic renal failure . symptomatic anaemia is caused by chronic renal fail .
do not use nespo if you have high blood pressure or are taking other medicines that are allergic to nesco ( darbepoetin alfa ) or r - huepo . if you suffer from high bloodpressure and are taking medicines to treat sickle cell anaemia . if your condition is not well controlled . if any of the above applies to you , tell your doctor before using nespos . warnings and precautions talk to your doctor or pharmacist before using neespo : if you are suffering from epileptic fits ( seizures ), convulsions or fits . if this is the case , please
your doctor will carry out blood tests before you start nespo to check your haemoglobin level . the usual starting dose is 10 micrograms per kg body weight . your doctor will then increase your dose to a haemogl level of 10 microg / kg bodyweight every 12 hours . the pre - filled syringe is for injection into a vein . in patients with chronic renal failure , a single injection is given under the skin into a veins ( intravenous ). your doctor may decide to increase your dosage if your anaemia is not controlled enough . your dose of nespos will depend on your body weight and your
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : 471 common ( may affect up to 10 in 100 people ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 , 000 people ): blood clots ( thrombosis ) pain in the area injected rash , redness and swelling of the skin rare ( may affects up to1 in 10 , 000 users ): serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of any face , lips
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the outer carton in order to protect from light . after first opening , you may remove your syringes from the refrigerator and store them at room temperature ( up to 30 ) for a single period of up to 7 days . do this at the end of this period . do away with nes
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection is a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . each pre -filled syringe contains the inactive substance darbasepoetein ala . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e487 ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and
macugen is a solution for the treatment of macular degeneration in adults . it contains the active substance pegaptanib . this medicine prevents abnormal formation of new blood vessels in the eye . macugen is used for thetreatment of macul degeneration . people with this disease have vision loss caused by damage to a part of the retina called the macula . macula is the thin layer at the back of the eye called the ' retina ' ( amd ). abnormal blood vessels grow in the retina and the macular area around the eye , causing these new blood structures to bleed and leak fluid causing the macla to bulge
do not use macugen : - if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you have an active or suspected infection in your eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have had an infection , including bleeding in the eye , stop using macug injection and contact your doctor immediately . if any of these apply to you , tell your doctor straight away . if your eye pain or increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light
insulin and injections you will be given macugen as a single injection into your eye , every 6 to 9 weeks . the injection will be injected into the vitreous part of your eye ( the front part of the eye ). macugen must be used every three weeks . antibiotic eye drops will be applied to the front of your eyes . you will also be given some local anaesthetic (umbing medicine ) to reduce any pain you may have after the injection . if you are allergic to antibiotic eyedrops , you will not be given antibiotic treatment if you have had eye infection . if macugen volume is injected too high ( intraocular
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction or angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea ) not known ( frequency cannot be estimated from the available data ) these side effects may be due to an infection in the internal portion of the eye . macugen treatment will help to reduce the symptoms described in section 2 . if you experience any of these symptoms , contact your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use the medicine if you notice that the solution is discoloured or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre -filled syringe
palifermin belongs to a group of medicines called escherichia coli . palifermin works by stopping the growth of epithelial cells in the mouth and digestive tract and by blocking their growth in the tissues below the skin . palififermin is used to treat oral mucositis ( soreness , dryness and inflammation of the mouth ), a common side effect that occurs during treatments for your blood cancer . if your bloodcancer is not treated with chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ( a procedure that removes blood cells to reduce the risk of side effects due to these
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children under 18 years of age . other medicines and kepivalance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . kepvelance may be taken with heparin . if you have recently been given heparrin , tell your physician . pregnancy and breast - feeding kepipivance is not recommended if you plan to become pregnant
how kepivance is given your doctor will decide how much kepivan you will receive . your doctor or nurse will decide the dose you will be given . your dose of cancer treatment will depend on your body weight . the usual dose of kepivalance is 60 mg . your first dose of kpivate will be administered to you by your doctor . the recommended dose is one kilogram ( kg ) of body weight given as an intravenous injection into a vein . how kepvelance is administered kepiper will be injected into your body once every three weeks . you will then receive chemotherapy together with radi
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth and tongue , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels , and increased levels of digestive enzymes in the blood . treatment usually lasts for
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder supplied in a vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcit which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinaconalcate accordphara is used : to treat secondary hyperparathyroidism in adults with serious kidney disease who are not on dialysis or who are unable to eliminate waste products that increase the amount of calcium in the bloodstream ( hypercalcaemia ). to treat parathy thyroid cancer that
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly before and during treatment with cinocalcut accordpha . warnings and precautions talk to your doctor or pharmacist before taking cinicalcvet accordphara : - if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have a history
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . you should take cinacealcate accordpharmat once a day for at least three weeks . the tablets should be taken with regular blood samples . your doctor will decide how long you should continue treatment . in patients with secondary hyperparathyroidism the usual starting dose of cinaconalcite accordphara is 30 mg once a week . c
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures ( these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in every 10
what cinacalcet accordpharma contains - the active substance is cinacealc . each film - coated tablet contains 30 mg , 60 mg or 90 mg cinacyl ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what ciniacalcel accordpharmaceutical looks like and contents of the pack cinaciaalcate
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformrin belongs to the class of substances called biguanides . they work together to lower blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empag
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has severely reduced kidney function . - if he / she has uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss . - this could lead to lactic acidosis ( see section " risk of lacticacidosis " below ). ketoacidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin as individual tablets , your doctor may prescribe a lower dose of linagliptin or metformatin . always take this medication exactly as described in this leaflet or as your pharmacist has told your doctor . check the box at the end of this leafle leaflet to make sure you are taking the right dose . if this medicine is not suitable for you , you may experience an upset stomach . the
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change and confusion . hypoglycemia is a very rare ( may affect up to 1 in 10 , 000 people ) side effect but can be life threatening . if you are treated with jentartueto plus sulphonylurea , or with the combination j
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the original package in order to protect from light . do this medicine if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metforman hydrochloric acid . - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol . what jentadaueto looks like and contents of the pack jent
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already infected with hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants is used in combination with hik medicines to treat adults and adolescents aged 12 months and older infected with either hiv or hiv . your doctor will discuss with you which combination of hiv medicine is best for you . medicines should not be given at the same time as edur
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent if you : are taking any of any of : the following medicines : carbamazepine , oxcarbazepine ( e . g . phenobarbital ), phenytoin ( medicines used to treat epilepsy and prevent seizures ) rifampicin , rifapentine ( medicines to treat some bacterial infections such as tuberculosis ) omeprazole , esomepraz
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( 18 years of age and older ) the recommended dose of edurant is one tablet once a day . do not take more than one tablet a day with food . do this if your doctor tells you to . do the following : - if you take rifabutin ( a medicine used to treat some bacterial infections ). if you think that the effect of edhurant is too strong or too weak , talk to your doctor . - if your dose of rifaberutin
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience headache , nausea , difficulty falling asleep , insomnia , dizziness , or changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your body , triglycerides , lipase and bilirubin
what edurant contains the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . each film - coated tablet of edurants contains rrilpiviraine hydro chloride equivalent to 25 mg ril pivirrine . the other ingredients are : the film - coating contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film coating contains : lactosemonohydrate , hypromellose 2910 ( e464 )
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with type 2abetes either don ' t make enough insulin to control their blood sugar levels or don 'T respond normally to insulin . rosigllitazONE and met formin work together by helping the insulin work better . this helps your body make better use of its blood sugar . avandamvet is also used as a sulphonylurea ( a type of medicine used to help you get better control of diabetes ).
follow all your doctor ' s instructions carefully . check with your doctor or pharmacist if you are not sure . your doctor will decide how much avandamet you need and for how long . do not take avandamanet if you : are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandammet ( listed in section 6 ) have had a heart attack have severe angina have heart failure have had heart failure in the past have severe breathing difficulties have liver disease have diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is taken once a day in the morning and once in the evening , at about 1 to 8 o 'clock . the maximum dose is 4 mg rosciglitrazone ( corresponding to 1000mg metforman ). thisdose is taken twice a day , at approximately 1 to8 o ' clock . the dose is also increased when you start to take
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet can include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamand and seek medical advice straight away . lactic acidosis ( a build - up of lactic acids in the blood ( lacticacidosis is a common side effect in patients taking metformin , especially if they have severe kidney disease ). symptoms of lact acid
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do away with the blister after you have taken them . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosigllitazon ( 500 mg ) metforman . each 2 mg tablet contains rosigslitazona ( 500mg ) met formin . each 3 mg tablet contain rosIGlitazome ( 1000 mg ) meetformin and each 4 mg tablet includes rosigglitazion ( 1000mg ) meet formin and the other ingredients are : sodium starch glycollate , hypromellose , microcrystall
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelmylan is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you have been
do not take clopidogrel mylan 31 if you are allergic to clopipidogel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before takingclopidigrel mylon : if you think any of this applies to you ( or you are not sure ), talk
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopideogrel melan contains hydrogenatedcastor oil '), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc , macrogl 3000
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ), in adults , adolescents and children . it is used as a medical procedure to reduce bleeding in adult patients . it works by reducing the number of platelets ( a type of blood cells that are important in the blood to clot and prevent bleeding ).
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using doptelelet if : you have ever had blood clots in the veins or arteries ( which may increase the risk of blood cl clots ) you have a history of bloodclots ( including cancer ) you are taking the contraceptive birth control pill or hormone replacement therapy you have recently had surgery or are seriously injured 23 you are overweight or have advanced chronic liver disease you are not sure if any of these apply
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to one 8 mg tablet twice a day depending on your response to doptelet . your dose of dopteol may be increased to 20 mg , 40 mg , 60 mg or 5 mg once a daily depending on the severity of your platelet counts . you should take this medication for 10 to 13 days before your planned medical procedure . swallow the tablet whole with some water . do not take a double
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches and fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormbopog maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries ( heart rate ) and the muscles in the heart . rapiscan is used in adults for the following types of heart scan : ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken using a thin needle to insert into the muscles of the heart using a readmill . a scan contains only a small amount of radiopharma and is injected into the body through a vein . your doctor or nurse will hand - stitch the pictures together
do not use rapiscan if you have slow heart rate or high degree heart block , sinus node disease or a pacemaker that does not work properly , chest pain ( unstable angina ), or treatment of low blood pressure ( hypotension ) or heart failure . if you are allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using rapiscen if any of these apply to you : if you think you may be at risk of having a recent serious heart problem , such as a heart attack , or if you
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of one hour . the recommended dose is 400 mg given as a 5 ml solution the injection will be administered over a course of one or two hours . the dose may be administered up to 10 mg depending on your weight . if you are given an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection , the dose will be increased to a maximum of 5 mg / kg . if a radioactive substance (
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects usually disappear after the rapiscin injection has been given within 30 minutes of any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be a sign of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . rapiscans may cause a stroke or cerebrovascular accident . if you have an allergic
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction or impotence . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have not been prescribed any of these medicines , please tell your doctor . - if the doctor has prescribed nitric oxide donors such as amyl nitrite , which may lead to an increase in your risk of a dangerous drop in yourblood pressure
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg . you should take viagra twice a day . viagra film - coated tablets are also known as viagra orodispersible tablets . you can take viagagra with or without food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . taking viagra with food viagra will help you to get an erection . you may also feel sexually stimulated when taking viaga . if you take more viagra than you should if you
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below have been seen with viagra . if you get any of the following side effects stop taking viagra and seek medical help straight away : an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . if this happens , chest pains may be severe and you may have to be in a semi - sitting position . you may also be given nitrates to relieve your chest pain . prolonged and sometimes
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildeneafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control the symptoms of primary parkinson ' s disease . it is used in combination with levodopa to treat parkinson '. sifrol is used to treat the symptoms associated with moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sifol . - if your doctor has told you that you have any medical conditions that could cause symptoms such as kidney disease . - hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are temporary . - dyskinesia ( abnormal , uncontrolled movements of the limbs ). if you have advanced parkinson ' s disease , you may be given levodopa to treat dyskineia . warnings and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . during the first week , the recommended starting dose is 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg per day ). your doctor may increase your dose to 1 tablet in the morning and to 0 . 012 mg in the evening . your doctor will increase your daily dose to 0. 088mg ( 0. 264 mg ) if your symptoms return but do not stop taking tablets .
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( might affect up to 1 in 100 people ) rare ( may affects up to1 in 1 , 000 people ) very rare ( might affects up in 1 to 10 , 000 patients ) not known ( frequency cannot be estimated from the available data ) if you have parkinson ' s disease , you may experience the following side effects : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ),
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , corresponding to 0 . 7 mg pramipxole ( as 0 . 125 mg ), 0 . 25 mg , and 0 . 5 mg , respectively . each tablets contains 1 mg pramsipexol dihydrochloride monohydrate . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the pack
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . allergic conditions occur in some parts of the body , especially around the eye , and the allergic reaction can be severe . allergic conjunctureitis may occur with some materials ( allergens ) that may cause allergic reactions such as itching , redness and swelling on the surface of your eye . if you experience any of these , tell your doctor immediately . if any of the signs of allergic conjugitis get worse , tell the doctor immediately and contact your doctor .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is under the age of 3 years because benzalkonium chloride has been present in the blood in children receiving emadadine ( see section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using emadin ). clinical trials have not been performed in patients receiving emADine . if you have kidney or liver problems , your doctor may decide to reduce the dose of emadina . other medicines and emadines tell your
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use adults use in adults use the recommended dose ( s ) once a day . use in children and adolescents use in infants and children 3 months of age and older and adolescents 1 year of age or older use in adolescents 2 years of age to less than 1 year old use in a child . do not use more than the recommended dosage . how to use the emadine bottle : wash your hands thoroughly before using it . the bottle can be removed from the bottle and
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops can cause some of these effects . common side effects ( may affect up to 10 in 100 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects : ( may effect up to 1 in 100people ) effects affecting the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneals staining , dry eye . general side effects include headache , difficulty sleeping , sinus headache , bad taste , rash . generalside effects
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections .
what emadine contains the active substance is emadastine 0 . 5 mg / ml . the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . each bottle contains one single - use syringe .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). levantiracetaman is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). leveiracetamer has been
do not take levetiracetam actavis - if you are allergic to levetiraacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking leveturacetamactavis - tell your doctor if you have kidney problems - tell his / her if you notice any slow down in the growth or unexpected puberty development of your child . anti - epileptics such as levetiralacetam actsavis have been associated with thoughts of harming or killing themselves . tell your physician if you or your child
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet of 1 , 000 mg once a day ( monotherapy ) the usual starting dose is 3 , 000mg once a week . your doctor may increase your dose to one tablet once a month ( monetration ) when you start taking levetvetiratam acta . your daily dose will be gradually
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest hospital emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ), flu - like symptoms and a rash on the face followed by an extended rash with a high temperature and increased levels of liver enzymes seen in blood tests ( a type of white blood cell ) 56 eosinophilia (
what levetiracetam actavis contains the active substance is levetviracetam . levetiraacetamactavis 250 mg : each film - coated tablet contains 250 mg of levetmiracetam ( as besilate ). levetvetir acetam actis 500 mg : one film - coating contains 500 mg of the active ingredient , levetiroacetam , each film film - coat contains 750 mg of a film - containing tablet , levevetiracam . each film coating contains 1 , 000 mg of one film film film- coated tablet , with the following ingredients : - tablet core :
ceremipa contains the active substance umeclidinium bromide which belongs to a group of bronchodilators called bronchioles . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways and airways in the lungs become damaged . this can lead to breathing difficulties . difficulties in breathing can also result in tightening of the muscles around the airway . this medicine blocks the tightening of these muscles , making it easier for air to get in and out of the lungs . this helps to control
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . incruruse ellipta should not be used in patients with asthma . talk to a doctor or nurse before using incruseyella if you : have heart problems have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ) have severe liver problems immediate breathing difficulties
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use incruse ellipta every day . if you use more incruce ellipta than you should if you have used more inculse elliptas than you have been told to use , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs , you may need to
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination . these may be signs of a urinary tract infection . common cold infection of nose and throat cough feeling of pressure and pain in the cheeks and forehead . these could be signs for inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalard should be used within 6 months . once the tray has been opened , the seal should be replaced . do this once the inhaluer has been removed from the refrigerator and has reached room temperature
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms umecylidinia . each adult delivers a delivered delivered dose ranging from 65 microgram to 65 micrograms umechloridinio . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrusea ellipta is an inhalation powder . the ellipta inhaler consists
what nucala is nucal contains the active substance mepolizumab , a monoclonal antibody . this type of protein is used to treat severe asthma in adults , adolescents and children from 6 years of age . severe asthma affects many eosinophils ( a type of white blood cell that helps the lungs breathe ) in and out of the lungs . eosinaophilic asthma is the most common form of asthma . nucalan is used in asthma attacks when medicines called high dose inhalers are not suitable to control your asthma . these medicines may be medicines called oral corticosteroids . how
do not use nucala : if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to treat your asthma with nucal . if your asthma does not respond to nucalan , your dose may be reduced or your doctor will stop nucla treatment . if you think you may be allergic , ask your doctor for advice . injection site reactions medicines of this type ( monoclonal
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week . the recommended starting dose is 1 mg given in the pre - filled pen . if you have any further questions on the use of nucala , ask your doctor or pharmacist . duration of treatment with nucal your doctor will decide how long you should continue to receive nuca . your doctor may decide to reduce the dose or stop the treatment with more nucale depending on your asthma symptoms and attacks . if your asthma symptom is not controlled with
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms may be severe and include symptoms such as chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to a similar reaction seen with nacala . other
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre pre -filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for up to 7 days in the refrigerator ( 1 8 ). discard the pre filled pen if it has not been used within 7 days . do away with the pre- filled pen once
what nucala contains - the active substance is mepolizumab . each vial contains 1 mg of 100 mg of mepolzumab - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale is a clear , colourless solution . it is supplied in a pack containing 1 vial or in a multipack containing 3 vials of 1 vials . not all pack sizes may
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib works by stopping cell survival . myelomas cells have a lot of proteins called ' proteases '. how does ninlary work ? when a person is given a medicine to treat multiple myelooma , it can kill a lot or stop the growth of a lot in the cells . how does this medicine work ? by stopping the production
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you . if you have any of those conditions , please tell your doctor . if any are not mentioned in this leaflet , please contact your doctor before taking this medicine . if your doctor thinks that any of them apply to your child , tell your child . warnings and symptoms talk to their doctor or nurse before taking the medicine if your child has : bleeding , persistent nausea ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of ninlaro is one capsule once a day . if you have multiple myeloma , your doctor may prescribe you a different dose . your doctor will tell you which dose of this medicine to take . the dose of the other medicine that you will take with ninlar is lenalidomide and dexamethasone . the first 4 - week course of treatment with ninlonaro is once capsule once daily on the same day of the week . the second 4 - weekly course
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the surface of the body ). rare side effects these may affect up to 1 in 1 , 000 people : severe skin rashes , red to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . once the capsule has been opened , use this product immediately . do no more than once a day . do this if you notice any damage or signs of tampering to the pack . do away with any medicine packaging that is damaged or shows signs of deterioration . do throw away any medicines via wastewater or household waste . ask your
what ninlaro contains the active substance in each capsule of ninlar 2 . 3 mg is ixazomib . each capsule contains 2 .3 mg ixezomib citrate . the other ingredients are : capsule content : microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. what ninlara looks like and contents of the pack the capsule is a white to off - white capsule with "
do not use palforzia if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palfORzia . children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because the medicine contains traces of peanut ( desensitisation ). palfiorzia is not intended to cause allergic reactions . palforbzia should not be used in children or adolescents with food allergies . if you have any further questions on the use of palfourzia , ask your doctor , pharmacist or nurse .
do not take palforzia if you are allergic to peanut or soya if you have severe asthma if your asthma is getting worse if you had a problem swallowing , or if you suffer from long term problems with your digestive system if you suffered from a severe mast cell disorder ( severe or life - threatening anaphylaxis ) if you cannot swallow peanut or it is not clear if any of the above applies to you . if you think any of these apply to you , talk to your doctor or pharmacist before taking palfORzia . warnings and precautions talk to you doctor or nurse before taking the tablets : if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . if you have had allergy or allergic reactions ( anaphylaxis ), your doctor may give you a lower dose ( 1 tablet once daily ) for 3 weeks . your doctor will determine the dose you need and will determine how long you need to take palforzia . initial doseescalation and up - dosing steps are given by your doctor . your physician will instruct you on how to start these treatment steps . the initial dose escalation and up d
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions : if you have any of the following symptoms while taking palforfzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin palforsia may cause problems with the stomach and digestive system ( eosinophilic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or particles in the vials . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfofen . each 0 . 5 mg capsule contains 1 mg , 10 mg or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg oral powder in capsules with opening microcrycrystallose cellulose ( e460 ), colloidal Anhydroussilica and and magnesiumstearate pregelatinised palfORzia 300 mg oralpowder in sachet microcry crystalline celluloses ( e464 ), colloid anhyd
zerne belongs to a group of substances called benzodiazepine - related medicinal products . these include hypnotic actions . zerene is used to treat sleeping problems in adults . it is indicated for treatment of problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes very weak and tired muscles , severe breathing and chest problems ). children and adolescents do not give this medicine to children and adolescent under 18 years of age because it has not been studied in this age group . warnings and precautions talk to your doctor or pharmacist before taking zeren : if any
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . if you have difficulty falling asleep , do not take more than the recommended dosage . if your doctor tells you to : - are 65 years of age or older - have mild to moderate liver problems - are over 65 years old - have 5 mg once daily - have moderate to moderate kidney problems - have a low dose of 5 mg per day . the capsule may become cloudy or coloured . this may indicate an overdose . if this happens , you may become increasingly
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or nurse if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 5 users in 1 , 000 ) rare ( affects less than 1 to 1 user of 10 , 000 ). very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) very rare : very rare
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( t171 ). - the printing ink contains gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphates ( e133 ), silicon dioxide , ( s - 13050 ). - printing ink containing shellac
